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Abstract 
 
 
A PRE AND POST EXERCISE COMPARISON OF THREE ASSESSMENT TOOLS 
COMMONLY EMPLYED TO ASSESS VASCULAR FUNCTION 
 
By: Lorena Salom, BS. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Masters in 
Science at Virginia Commonwealth University 
 
Virginia Commonwealth University 
 
 
Major Director: Dr. Ronald K. Evans 
 Department of Health and Human Performance 
 
 
 
Clinical research efforts have recently focused on the detection of subclinical 
indicators and precursors of cardiovascular disease (CDV), including endothelial 
dysfunction (ED).  Several vascular assessment tools have been developed as a means of 
detecting early alterations in vascular responses and subsequent characterization of ED.  
However, three of the most commonly employed techniques have several methodological 
differences, including the fact that each technique evaluates a different component of the 
vasculature.  Flow mediated dilation (FMD) via ultrasound evaluates vascular function of 
the large conduit vessels such as the brachial artery.  Strain gauge plethysmography 
(SGP) measures vasodilatory capacity of resistance vessels by assessing forearm blood 
flow.  Lastly, Peripheral artery tonometry (PAT) evaluates the ratio of pulse wave 
amplitude (PWA) by assessing the microcirculation of the fingers.  While these measures 
are typically performed during a resting condition, there has been recent interest in  
 9
vii 
evaluating vascular responses following an acute bout of exercise.  The documents 
contained herein include a review of the relevant literature related to mechanisms of 
vessel function, assessment of vascular dysfunction using non-invasive tools, and 
vascular responses brought on by different types and intensities of exercise.  Additionally, 
a manuscript is included which details a pilot research study designed to compare the pre- 
and post-exercise reactive hyperemia responses to 5 minutes of occlusion as evaluated by 
SGP, FMD and PAT in apparently healthy, untrained males.  Relationships among the 
primary outcome variables obtained from the three techniques both before and after 
exercise are also evaluated.  It is our hope that this initial pilot study in apparently healthy 
subjects will provide a foundation on which to develop a vascular function assessment 
protocol that will improve early detection of ED and therefore earlier intervention and 
ultimate reduction of CVD mortality. 
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I. INTRODUCTION 
 
Cardiovascular Disease (CVD) continues to be the leading cause of death 
worldwide (He & MacGregor, 2009).  Recently, researchers have shifted their attention 
to recognizing the preliminary signs of CVD, in hopes of preventing and reversing the 
early development of vascular abnormalities.  Subclinical indications of CVD include 
vessel wall abnormalities and delayed vascular responses. Vascular reactivity refers to the 
morphological and physiological changes that blood vessels undergo in response to a 
stimulus. This self-regulation of tone and adjustment to changes in blood flow are 
endothelium-dependent, and imperative to normal vascular function. Impaired 
endothelium-dependent vasodilation is the main manifestation of poor vascular reactivity, 
and could predict the risk of cardiovascular incidents (Schächinger, Britten & Zeiher, 
2000).  In fact, endothelial dysfunction (ED) has been shown to be a stronger predictor of 
cardiovascular disease than classic risk factors for coronary artery disease such as 
hypertension, hypercholesterolemia, smoking, family history, and evidence of 
atherosclerosis incidents (Schächinger, Britten & Zeiher, 2000).  ED is defined as the 
progressive development of irregular vascular function, such as abnormal vessel tone, 
loss of the endothelium’s atheroprotective properties, and most notably, diminished nitric 
oxide (NO) availability (Vane, Anggård & Botting, 1990, Quyyumi, 1995). Fortunately, 
ED is considered to be a treatable stage of CVD development. 
Cardiovascular disease treatments range from medicinal regimens to high risk 
invasive surgical procedures.  Angiotensin-converting enzyme (ACE) inhibitors, 
angiotensin receptor blockers (ARBs) and beta-adrenergic antagonists are commonly 
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used drug therapies for hypertension, coronary artery disease and other vascular 
complications (Gustafsson, Segura & Ruilope, 2010).  Although mostly effective at 
preventing cardiovascular events, some patients on such therapies will still develop heart 
failure regardless of the type of drug therapy (Verdecchia, et al., 2009).  Invasive 
procedures also known as percutaneous coronary interventions (PCIs) include 
angioplasty and stenting (Hashemi, et al., 2010).  PCIs are common and effective 
procedures in the treatment of various cardiovascular diseases, yet these invasive 
procedures are risky and recovery can be an arduous process (Hashemi, et al., 2010).  The 
ineffectiveness and risk associated with cardiovascular disease treatment accentuates the 
importance of early detection of ED, thereby preventing the full development of 
cardiovascular disease. 
Three commonly employed clinical and research tools to evaluate vascular function and 
detect ED include brachial artery flow-mediated dilation (FMD) via ultrasound, venous 
occlusion strain-gauge plethysmography (SGP), and peripheral artery tonometry (PAT).  
All three techniques utilize a pressure cuff that is inflated to suprasystolic pressure 
(240mm Hg) for five minutes, substantially minimizing blood flow to the limb.  
Following the rapid release of the cuff, oxygenated blood rushes into the hypoxic area 
inducing rapid vasodilation in a process known as reactive hyperemia. The extent of the 
vessel’s reaction to this process, as well as the time frame in which it occurs, are markers 
of vasomotor function (Corretti, et al., 2002 & Dhindsa et al., 2008).  While all three 
tools have shown a strong ability to evaluate specific parameters related to vascular 
health, they do so by evaluating different components of the cardiovascular system.  By 
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combining their different diagnostic abilities, early CVD detection and prevention may be 
substantially enhanced.  
Brachial artery flow-mediated dilation (FMD) evaluates vascular function of the 
large conduit vessels such as the brachial artery, which allow for increased blood flow to 
large areas (Segal & Durling, 1986).  FMD utilizes high resolution ultrasound imaging to 
scan and measure the diameter of the brachial artery at rest and during hyperemic 
conditions.  The magnitude and speed of the brachial artery diameter change is indicative 
of endothelial function, which is impaired in patients with coronary atherosclerotic 
lesions (Zeiher, Schächinger & Minners, 1995).  Moreover, recent research has further 
pinpointed the location that the FMD technique is evaluating.  It was previously believed 
that impaired FMD was reflective of abnormal microcirculation, but more recent studies 
have found that it directly indicates atherosclerotic processes occurring in the conduit 
brachial artery (Padilla et al., 2009).  The CVD predictive ability of FMD has been 
extensively explored in many healthy and clinical populations, and although confounding 
results have been found, there is a general agreement that brachial artery FMD is a useful 
tool in the classification of subjects into low, intermediate, or high-risk CVD categories 
(Yeboah et al., 2009).   
Venous occlusion strain gauge plethysmography (SGP) has been utilized to assess 
forearm blood flow as a marker for vascular function. A mercury-filled strain gauge is 
wrapped around the thickest portion of the forearm, and it senses the magnitude of 
forearm diameter change during a time when venous outflow is occluded, which allows 
calculation of arterial inflow at baseline and after an occlusive stress.  The reactive 
hyperemia induced forearm blood flow (FBF) responses denote vasodilatory capacity of 
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resistance vessels, an indicator of vascular health (Patterson, 1955). SGP has proven 
effective at detecting ED. (Shechter, Matetzky, Arad, Feinberg & Freimark, 2009). 
Peripheral artery tonometry (PAT) is an innovative technique recently developed 
to detect ED by determining pulsatile blood volume changes in the fingers. In contrast to 
the assessment tools mentioned above, PAT assesses pulsatile capillary blood flow, 
which is responsible for blood flow for localized areas such as the fingers and toes 
(Hamburg & Benjamin, 2009). Specifically, PAT evaluates the ratio of pulse wave 
amplitude (PWA) during reactive hyperemia compared to baseline values to determine 
the degree of ED (Heffernan, et al., 2010). The PWA ratio, also referred to as the PAT 
Reactive Hyperemic Index (RHI), is becoming an accepted measure of microvascular 
ED. Moreover, it has been found to be significantly related to the widely accepted 
criterion for ED evaluation, brachial artery FMD (Heffernan, et al., 2010). 
The protective effects of exercise on the cardiovascular system in particular have 
been the focus of research in the last few decades. The importance of physical activity on 
general health has been well recognized and advocated by health organizations such as 
the American College of Sports Medicine and the American Heart Association. The 
Surgeon General recommends 30 minutes of moderate intensity physical activity on most 
days of the week to acquire the beneficial health effects of exercise (www.cdc.gov).  
Some of these beneficial effects include but are not limited to improvements in CVD 
factors such as high blood pressure, LDL cholesterol, triglycerides and body weight 
(Paffenbarger, Jung, Leung & Hyde, 1991).  Exercise has also been shown to increase 
insulin sensitivity in healthy subjects and decrease insulin resistance in obese and type 2 
diabetes patients (Scheen & Paquot, 2001). 
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 The effects of an acute bout of exercise on vascular function in several different 
populations have been evaluated utilizing SGP, PAT and FMD.  Using SGP to assess 
vasodilatory responses, it was found that FBF was significantly higher following an acute 
bout of exercise when compared to resting FBF in both endurance and resistance trained 
athletes (Baynard , Miller, & Fernhall, 2003).  This same study determined that one bout 
of acute maximal exercise increased vasodilatory capacity in both groups.  Significant 
increases in brachial artery diameter have been detected by FMD via ultrasound 
following an acute bout of low intensity exercise, and even greater increases after an 
acute bout of high intensity exercise in overweight active and inactive men. (Harris, 
Padilla, Hanlon, Rink & Wallace, 2008). Similar findings were observed in studies 
investigating the effects of exercise on vascular responses evaluated by PAT (Levin, et 
al., 2001).   In subjects with coronary artery disease (CAD), altered peripheral vascular 
responses were detected during and three minutes following a routine exercise protocol 
(Levin, et al., 2001).  Altered peripheral vascular responses included abnormal PAT 
indices, increased vasoconstriction during the acute exercise bout, as well as less 
vasodilation following the exercise.  
 Although all three techniques have shown to successfully detect exercise induced 
vascular changes in different vessel types, all three techniques have not been compared 
and contrasted pre and post-acute exercise.  Furthermore, some studies have found 
diminished vascular function following an acute bout of exercise in diseased populations 
(Sylvestro et al.; Mcgowan, et al., 2006).  Since the stress applied to the cardiovascular 
system by exercise may alter vascular responses to an occlusive stress, assessment of 
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vascular function after a quantitative exercise stress may provide additional predictive 
value related to the health of the vasculature.  
This document has been organized to include a thorough review of the relevant 
literature related to vessel function and assessment of vascular dysfunction using non-
invasive tools.  Additionally, vascular responses brought on by different types and 
intensities of exercise will be presented.  The review of literature is followed by a 
manuscript titled  “A pre and post-exercise comparison of three assessment tools 
commonly employed to evaluate vascular function”, which details a pilot research study 
designed to  compare the pre- and post-exercise reactive hyperemia responses to 5 
minutes of occlusion as evaluated by FMD, SGP, and PAT.  For each assessment tool, 
pre- and post-exercise vascular function responses were evaluated in apparently healthy, 
untrained, non-obese males.  Additionally, relationships among the primary outcome 
variables obtained from the three techniques both before and after exercise were 
evaluated.   
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II. REVIEW OF RELEVANT LITERATURE 
The vascular system is composed of the vessels of the body, including the 
arteries and veins and its main purpose is to circulate blood to all body tissues.  The 
task of providing tissues with sufficient oxygenated blood to meet metabolic demands 
is of primary importance, and it emphasizes the need for a comprehensive 
understanding of vascular function.  Unfavorable changes in endothelial function and 
arterial stiffness, hence changes in vascular function, are thought to be predictors of the 
development of cardiovascular disease (Wilson, 2005).  Detecting these changes may 
be beneficial for early detection and prevention of cardiovascular disease, as well as the 
determination of  the prognosis for future cardiovascular events.  Several non-invasive 
tools have been developed and are utilized to evaluate vascular function including 
brachial artery flow-mediated dilation (FMD) via ultrasound, venous occlusion strain-
gauge plethysmography (SGP), and peripheral artery tonometry (PAT) (Alomari et al., 
2004; Wilson, 2005) 
 The following is a review of the scientific literature related to vascular 
function, molecular mechanisms related to vascular tone, pathogenesis of 
atherosclerosis, and the clinical assessment of vascular function utilizing non-invasive 
tools.  The review is structured to 1) provide background on the function of the 
endothelium, 2) provide a detailed description of commonly employed non-invasive 
tools for assessing vascular function and their utilization as prognostic indicators of 
cardiovascular disease, and 3) provide a review of alterations in vascular function 
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brought about by acute and chronic exercise training which may influence vascular 
function.  
The Endothelium and Vascular Function 
 
The interior surface of all blood vessels is lined by a single layer of endothelial 
cells that function as a metabolically active barrier between blood in the vessel lumen 
and the blood vessel wall (Terzuoli, Marinello, Frosi, Ciari, & Porcelli, 2008). 
Endothelial tissue can also be found in the interior surface of lymphatic vessels and the 
heart.  An important feature of the endothelium is its ability to detect changes in blood 
flow hemodynamics as well as to react to these changes by making appropriate 
modifications to return to vascular homeostasis (Simionescu & Antohe, 2006).  The 
endothelium-dependent response to these changes in hemodynamics includes the 
secretion of both vasodilating substances (e.g., nitric oxide (NO) and endothelium-
derived hyperpolarizing factor (EDHF)) and vasoconstricting substances (e.g., 
Endothelin 1 and Angiotensin II), which directly affect vascular tone and vascular 
reactivity (Verma & Anderson, 2002).  
In addition to being an endothelium-derived relaxing factor, NO also contributes 
to vessel homeostasis by regulating vascular function.  Derived from L-arginine, NO 
possesses essential properties that maintain endothelial function and vascular reactivity, 
such as hindering platelet aggregation and adherence to blood vessel walls (Ignarro, 
1989). In fact, reduced NO bioavailability is a primary contributor to endothelial 
dysfunction (Yao et al., 2010).  Endothelial dysfunction is considered to be the earliest 
clinical indication of risk for cardiovascular diseases, and is closely related to a series 
of severe chronic and acute illnesses such as arthrosclerosis, multi-vessel coronary 
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artery disease, diabetes mellitus, hypertension, and stroke (Kitta et al., 2009).  
Opposing the vasorelaxing effects of NO is an active vasoconstricting peptide, 
Angiotensin II (ATII) (Johren, Dendorfer, & Dominiak, 2004).  ATII is a potent 
vasoconstrictor which works directly on the vascular system through G-protein coupled 
receptors, or indirectly by facilitating aldosterone and norepinephrine release (Johren, 
Dendorfer, & Dominiak, 2004).  An increase in expression of ATII Type 1 receptors 
(AT1R) has been strongly linked to atherosclerosis (Libby, 2002).  Moreover, it has 
been found that over-expression of the ATII Type 2 receptor (AT2R), which opposes 
the effects of AT1R, reduces atherosclerotic lesion formation, playing a protective role 
against cardiovascular disease (Hu et al., 2008).   In addition, studies have found that 
ATII regulates the activity of endothelial nitric oxide synthase (eNOS), the enzyme that 
catalyzes the formation of NO from L-arginine (Kawashima & Yokoyama, 2004).  A 
deficit of this important enzyme has been observed in patients with atherosclerosis, as it 
reduces NO bioavailability (Kawashima & Yokoyama, 2004).  The vascular role of 
ATII has been thoroughly investigated, and its activity has been selectively opposed by 
AT2R receptor activation, involving the endothelial dependent bradykinin pathway and 
NO production (Hannan, Davis, & Widdop, 2003). 
Another potential mechanism contributing to the development of endothelial 
dysfunction involves the signaling G protein GTPase RhoA and its target Rho kinase 
(ROCK), which is directly involved in T-cell transendothelial migration, thrombus 
formation, and regulation of the endothelial barrier integrity (Yao et al., 2010).  
Detrimental effects on endothelial function are observed with the overactivation of 
RhoA/ROCK resulting in reduced eNOS expression, hence a decreased NO 
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bioavailability.  Furthermore, ROCK inhibitors reverse this effect, upregulating eNOS 
expression and NO production (Yao et al., 2010) 
Disruption of the activity of vasoactive substances such as NO and ATII can 
severely alter vascular balance and may lead to endothelial dysfunction. In addition to 
the endothelium, these vasoactive substances also target the smooth muscle cell layer of 
the vessel wall, causing vasoconstriction or vasodilation.  The role of smooth muscle 
cells in vascular function is critical to maintaining vascular health, and their interaction 
with vasoactive substances will be further explored below. 
Smooth Muscle Cells and their role in Vascular Function 
Surrounding the endothelial layer is a thick layer of smooth muscle cells 
constituting the media layer of the vessel wall. Vasoconstriction and vasodilation are 
mediated by the tonic vascular smooth muscle cells, which behave as multiple, 
independent units resulting in graded changes in vascular tone (Fisher, 2010). 
Specifically, NO diffuses into the media, and binds to the guanylyl cyclase receptors 
starting a cascade of events resulting in an increase in the second messenger cGMP. 
Subsequently, this reaction arbitrates vascular processes such as vasorelaxation, 
inhibition of platelet activation and migration (Bassil & Ananda-Srivastava, 2007).  The 
dual effects of vasoactive substances on both the metabolically active endothelium and 
on vascular smooth muscle cells compound the significance of their role on vascular 
homeostasis and prevention of vessel-related pathogenesis.  
Blood vessel types and their mechanisms 
There are three major types of blood vessels which differ greatly in size, 
function and blood flow control mechanisms.  SGP evaluates vascular reactivity of 
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resistance vessels, FMD focuses on conduit vessels, and Endo-PAT assesses the 
capillaries. Resistance vessels are 50µm or smaller in diameter and are in command of 
regional blood flow, whereas conduit vessels such as the brachial artery are much larger 
with diameters of several millimeters, allowing for increased blood flow to large areas 
(Segal & Durling, 1986). During exercise, blood flow to the muscles is mainly dictated 
by resistance vessels, which occurs via a NO-mediated function, as well as cardiac 
pump capacity, muscular pump, and the sympathetic system (Saltin B., Radegram G., 
Koskolou M., Roach R., 1998).  The significantly smaller capillaries are responsible for 
microcirculation, providing blood flow for localized areas such as the fingers and toes. 
Digital vascular function at rest and during hyperemic responses has been thoroughly 
investigated and directly correlates to vascular function in other regions (Hamburg & 
Benjamin, 2009).  The differences and similarities in vascular reactivity for each vessel 
type following a stressor require further investigation. 
Hormonal and Gender effects on Vascular function 
Hormones closely linked to the menstrual cycle, such as estrogen and 
progesterone, have a direct effect on the endothelium (Lynn, McCord, & Halliwill, 
2006).  Estrogen receptors are found on the endothelium and estrogen binding elicits 
NO release, augmenting a common endothelium relaxing mechanism (Deroo & 
Korach, 2006).  Elevated estrogen levels in females, and their enhancing effects on 
endothelium relaxing mechanisms further denote gender-related differences in vascular 
function. These hormonal differences may be advantageous for cardiovascular health in 
menstruating females when compared to males.  Additional findings state that 
endothelial progenitor cells implicated in cardiovascular homeostasis were found to 
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oscillate in phase with the menstrual cycle in ovulating women (Fadini et al., 2008).  It 
is hypothesized that endothelial progenitor cells migrate to the peripheral circulation 
during the different phases of the menstrual cycle, and higher levels are found in 
ovulating women than in post-menopausal women and males (Fadini et al., 2008).   
Future vascular function studies should include females during the various menstrual 
cycle phases in order to apply the findings to benefit a larger segment of the population 
with the incremental knowledge of endothelial dysfunction detection and treatment.  
Additionally, the vasorelaxing effects of estrogen should be further investigated as a 
potential hormonal therapy for CVD treatment. 
 In addition to gonadal steroids, other important hormones alter vascular 
mechanisms. Acute augmentations of growth hormone (GH) not only provoke 
endothelium dependent vasodilation marked by increased NO synthesis, but also 
increased sensitivity to vasodilating agents (Napoli et al., 2003).  This study also 
suggests the potential therapeutic role of GH on vascular pathogenesis. 
Assessment of Vascular function 
Assessment of endothelial dysfunction has become increasingly important as the 
prevalence of CVD has dramatically risen in the last several decades.  There are several 
non-invasive assessment tools available to evaluate vascular function.  Three of the 
most commonly utilized assessment tools are flow mediated dilation (FMD), strain 
gauge plethysmography (SGP), and peripheral artery tonometry (PAT). All three 
measurement techniques attempt to occlude all blood flow to the limb with a pressure 
cuff inflated to supra systolic pressures, creating a hypoxic state. Reactive hyperemia, a 
compensatory vascular increase in blood flow to the occluded area to reestablish 
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oxygen blood to ischemic tissues, occurs as a result of the deflation of the pressure cuff 
(Pyke & Tschakovsky, 2007).  How quickly the vessels react to these changes reveal 
the health of the vasculature.  Although all three assessment tools evaluate vascular 
health, they do so  by assessing the vascular reactivity of different types of vessels.  
SGP evaluates vascular reactivity of resistance vessels, FMD focuses on conduit 
vessels, and PAT assesses vascular function of the microcirculation.  To date, there 
have been no studies in which vascular function has been evaluated across different 
vessel types at rest and following an acute exercise bout.  
 Abnormalities in the vasodilatory and vasoconstrictive abilities of vessels are a 
feature of endothelial dysfunction, a precursor of more serious vascular diseases such as 
atherosclerosis, heart disease, and diabetes (Vogel, 2001).  Furthermore, it has been 
found that endothelial dysfunction is significantly more prevalent in diseased 
populations such as patients with Diabetes Mellitus and Coronary Artery Disease 
(CAD) (Tagawa et al., 2004), highlighting the need for reliable endothelial dysfunction 
evaluation tools for early detection and prevention of cardiovascular disease and other 
related illnesses in already vulnerable, unhealthy populations.  
Vascular function and its homeostasis require intricate interactions and co-
relationships amongst different cell types, hormones, vasoactive substances, and it is 
affected by diurnal variations. It is imperative to take these relationships into account, 
and to control for them during vascular function studies as they may represent 
confounding variables. The next few sections will explore in detail the techniques and 
measurement issues related to FMD, SGP, and PAT.  
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Flow mediated dilation. Brachial artery flow-mediated dilation (FMD) is a frequently 
used method which employs high resolution ultrasound to measure brachial artery 
diameter (Verma, Buchanan, & Anderson, 2003).  FMD measures macrovascular 
reactivity and is used to identify subclinical CVD markers in at risk patients (Dhindsa 
et al., 2008).  Although a trained ultrasonographer is necessary in order to effectively 
assess vascular function with FMD, a study found difficulties finding the brachial artery 
in only 3% of the population being studied, obtaining FMD values for 97% of the 
subjects (Lind, Fors, Hall, Marttala & Stenborg, 2005).  Initial scanning of a segment of 
the brachial artery at rest provides a baseline vessel diameter which is subsequently 
compared to a post-occlusion reactive hyperemic diameter.  In addition to producing 
reactive hyperemic vasodilation following the pressure cuff release, several studies 
have utilized artificial means to induce endothelium-independent vasodilation, such as 
the administration of sublingual nitroglycerin as a means of determining maximal 
vasodilatory capacity (Lierberman et al., 1996; Lierberman et al., 1994). Although an 
efficient method to produce vasodilation, nitroglycerin-induced vasoactivity does not 
reflect an individual’s vascular health.   
 FMD has been found to be a valuable tool in the early detection of 
cardiovascular disease risks, and it is considered the gold standard for diagnosing 
endothelial dysfunction (Celermajer et al., 1992; Harris, Padilla, Rink, & Wallace, 
2006; Peretz et al., 2007).  This technique has been successfully used in a vast range of 
populations including children and adults in attempts to detect these preclinical 
cardiovascular disease precursors (Al-Qaisi, Kharbanda, Mittal & Donald, 2008).  
Additionally, FMD has been found to be a promising CVD detection tool in 
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asymptomatic patients when reactive hyperemia values stray from expected values for 
healthy individuals (Celermajer et al., 1992).  In a 2005 study, Lindt et al. compared 
FMD to other invasive and non-invasive vascular function assessment tools and 
reported average values measured by these techniques in healthy young and healthy 
elderly populations.  The healthy young group had lower brachial artery diameter and 
maximal diameter, and higher diameter change and % FMD when compared to the 
elderly healthy group (Lind, Fors, Hall, Marttala & Stenborg, 2005).  Noteworthy 
values reported in this study for the healthy young group include baseline brachial 
artery diameter (3.1 ± 0.5mm), maximal diameter (3.4 ± 0.4mm)  and a 9.4% FMD 
change representing the percent change in artery diameter at baseline and following the 
occlusion.  The same study also demonstrated that FMD values decreased with age.  
Other important relationships found when investigating the association of FMD in 
healthy men were that FMD is directly related to resting wall shear stress, and that a 
negative and direct correlation exists between shear stress determinants such as arterial 
diameter and flow velocity. (Gnasso, 2001).  In epidemiology studies, brachial artery 
FMD has consistently demonstrated debilitated vascular functions in subjects exhibiting 
cardiovascular disease risk factors. Significantly lower brachial artery FMD was found 
in moderately obese pre-pubertal boys without insulin resistance, both at rest and 
during exercise. (Karpoff et al., 2009). A subsequent study reiterated the ability of 
FMD via ultrasound to detect endothelial dysfunction, as it was found that this method 
successfully identified the functional state of the endothelium in patients with 
cardiovascular disease risk factors (Atkov, Balahonova & Pogorelova, 1998).   
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The addition of exercise as a stressor to the cardiovascular system was assessed 
with FMD in several studies.  The results indicated that highly endurance-trained 
athletes have larger arterial diameter but similar endothelial-dependent vasodilation 
when compared to untrained controlled subjects (Rognmo et al., 2008).  Additionally, it 
has also been reported that NO-dependent vascular mechanisms occur in 45 to 60 
seconds in healthy individuals following FMD caused ischemia (Celermajer et al., 
1992), and the response to acute endurance exercise measured by FMD has shown to be 
highly dependent on the time following exercise. Obtaining vascular function 
assessment in a timely manner is therefore a necessary factor for valid post-exercise 
vascular function evaluation. 
Although the evidence presented above has shown FMD to efficiently assess 
vascular function, studies comparing FMD to other vascular function assessment tools 
have found contradictory results.  When FMD was compared to increases in forearm 
blood flow obtained by SGP, both assessing peripheral vascular endothelial 
vasodilatory capacity, it was found that there was no significant correlation between the 
two (Eskurza, Seals, DeSouza, Christopher  & Tanaka, 2001; Gori at al. 2006).  The 
reasoning behind this discrepancy was attributed to the different macro and 
microvascular properties influencing each technique (Dhindsa et al., 2008).  The same 
theory was applied to the lack of association between FMD and reactive hyperemic 
flow, and FMD and sheer stress, although both factors are known stimuli for FMD 
(Dhindsa et al., 2008).  On the contrary, a 2007 study found that reactive hyperemia and 
FMD were significantly reduced in patients with cardiovascular disease risk factors 
(Huang et al., 2007). This method’s reproducibility and repeatability have been 
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previously established, and it was found that FMD possesses a very low coefficient of 
variation for in vivo measurements for flow mediated dilation (Sorensen et al., 1995) 
and a coefficient of repeatability of 4% for baseline brachial diameter measurements 
(Rognmo et al., 2008). 
While this method is non-invasive and clinically useful, it has several 
limitations for clinical use including the significant cost of the equipment and the need 
for a trained ultrasonographer.  Additionally, the lack of a consistent protocol for the 
utilization and interpretation of FMD has also contributed to variations in clinical 
findings.  For example, a recent study found an 8.9% difference in magnitude of 
brachial artery flow mediated dilation following proximal occlusion of the upper arm 
versus distal occlusion of the forearm (Peretz et al., 2007).  It is therefore warranted to 
develop a standard pneumatic cuff occlusion location for the clinical utilization of 
FMD.  Furthermore, differences in day to day variability in vessel diameter due to 
biological circadian rhythms have also been observed (Verma et al., 2003) and  a 
diurnal effect due to increased sympathetic nervous system activation has been proven 
to influence FDM, providing erroneous, decreased readings (Hijmering et al., 2002).  It 
is important to note that no effects have been found on FMD readings due to repetitive 
bouts of reactive hyperemia up to a two hour period; providing flexibility for different 
research designs (Harris et al., 2006).  Implementation of a new FMD vascular function 
assessment protocol should take the previous potential measurement issues into 
consideration in order to minimize measurement error.  
Strain Gauge Plethysmography.  Another common technique to assess vascular 
function is strain gauge plethysmography (SGP), which is utilized to evaluate both 
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baseline and post-occlusion forearm blood flow.  In this method, a pressure cuff is 
placed on the upper arm and the wrist.  Inflating the proximal cuff creates an upper arm 
occlusion (~40 mmHg) and produces sufficient pressure to occlude venous blood 
outflow from the limb, yet arterial inflow is unaffected. As arterial blood continues to 
enter the limb and venous return is impeded, the volume of the limb increases. The 
wrist cuff is inflated to a suprasystolic pressure to prevent blood flow into the hand.  
The change in limb circumference is assessed by a mercury-filled strain gauge placed 
around the forearm.  Following a determination of baseline forearm blood flow, blood 
flow is occluded by inflating the upper arm cuff to a suprasystolic values (>200 
mmHg).  After five minutes of occlusion, the cuffs can be quickly deflated and forearm 
blood flow can be assessed during the period of reactive hyperemia.  The reactive 
hyperemic blood flow response is often quantified as an area under the curve during the 
three minute period immediately following release of the upper arm cuff (Bousquet-
Santos, Soares, & Nóbrega, 2005).  SGP’s ability to measure vascular function, 
reproducibility, and relationships between different physiological findings were 
assessed.  Mercury-filled SGP was found to be a reproducible vascular assessment tool, 
as established by the evaluation of forearm arterial and venous indexes both at rest and 
post a 5 minute brachial artery occlusion at 240mm Hg on thee different occasions 
(Alomari et al., 2004).  Some notable findings regarding physiological relationships 
found in the previously mentioned study include the association between handgrip 
strength, venous capacitance and outflow; as well as the suggestion of a link between 
venous function and exercise performance (Alomari et al., 2004).  In agreement to the 
general concept that exercise enhances a variety of cardiovascular parameters, baseline 
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FBF and vascular reactivity were appreciably improved following an acute maximal 
aerobic exercise bout.   
Due to the proven reliability of this assessment tool, SGP has been used to test 
the assumed physiological effects of various substances on the vasculature. The 
nonessential amino acid L-arginine, a precursor to NO, has been found to increase 
blood flow in healthy individuals (Campbell, La Bounty & Roberts., 2004) and is being 
marketed as a supplement that increases nutrient and oxygen delivery to muscle, 
increasing muscle size during and following resistance exercise. Using SGP, it was 
found that FBF was unchanged following the ingestion of L-arginine prior to resistance 
exercise; contradicting the marketing claims of the vascular enhancement faculties of 
L-arginine supplements (Fahs, Heffernan & Fernhall, 2009). 
 The combination of SGP with other vascular assessment tools has been used in 
some clinical studies to assess CVD risk factors. Merging the SGP and FMD 
techniques, researchers used brachial artery blood velocity values measured by FMD 
and forearm blood flow values determined by SGP to calculate brachial artery diameter 
in a young healthy population. A strong correlation was found between the two 
methods at rest.  Moreover, forearm heating-induced increases in forearm blood flow 
and blood flow velocity were accompanied by large increases in brachial artery 
diameter (Sinoway, Hendrickson, Davidson, Prophet & Zelis, 1989).  Yet when 
increases in forearm blood flow were compared to changes in FMD, both assessing 
peripheral vascular endothelial vasodilatory capacity, it was found that there was no 
significant correlation between the two. (Eskurza, Seals, DeSouza, Christopher & 
Tanaka, 2001; Gori et al. 2006).  The combination of more than one vascular function 
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assessment tool should be further investigated, as it may strengthen CVD diagnostic 
and preventive abilities.  
Peripheral artery tonometry.  More recently, a clinical assessment tool utilizing 
peripheral artery tonometry (PAT) technology and marketed under the brand name 
Endo-PAT® has been developed to assess microcirculation in the fingers as a means of 
evaluating vascular function.  This technique utilizes a PAT signal obtained via a 
modified plethysmography finger probe that measures blood volume changes before 
and after 5  minutes of upper arm occlusion.  While there is a significant expense for 
the Endo-PAT® unit and the single use finger probes, the use of the unit does not 
require extensive expertise or training to operate (Selamet Tierney, 2009).  Latex finger 
probes are placed on index fingers of both hands and following an initial baseline 
assessment, blood flow is assessed for five minutes following a five minute upper arm 
occlusion.  Since this technique uses a latex finger cuff and assesses blood flow at the 
nail bed, PAT cannot be utilized on patients who are either allergic to latex or have long 
or acrylic finger nails.  According to the manufacturer’s website, a PAT score of 1.67 
or lower indicates a need for medical assessment of the cardiovascular system, a score 
between 1.68 and 2.0 reflects a need for a reduction of lifestyle CVD risk factors such 
as smoking and  being overweight, whereas a score of 2.1 or higher signifies a healthy 
endothelium (http://www.itamar-medical.com/).  A recent study observed acceptable 
reproducibility and reliability of the PAT technique with insignificant within-subject 
variability in healthy adolescents (Selamet Tierney, 2009).  
Endo-PAT has been used to measure endothelial function differences in several 
chronic disease populations, including those with high global cardiovascular risk 
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(HCVR) and human immunodeficiency virus (HIV). The author’s primary observation 
was that patients with HCVR and HIV have diminished endothelial function when 
compared to healthy subjects (Ferre, Plana, & Coll, 2007).  Several epidemiologic 
studies have found that people who work for long shifts are at a heightened risk for 
cardiovascular disease due to arterial hypertension, hyperlipedimia and metabolic 
syndrome (Knutsson, Jonsson, Akerstedt & Orth-Gomer, 1986; Sookoian et al., 2007; 
Suwazono, et al., 2008; Dochi, et al., 2009).  More recently, these findings were 
confirmed by lower PAT scores in shift workers when compared to non-shift workers, 
indicating endothelial dysfunction (Suessenbacher, et al., 2011). 
When comparing this technique to the gold standard vascular function 
assessment tool, FMD, conflicting results have been found. In a vascular function 
assessment tool comparison study, it found that PAT does not have a high correlation 
with FMD (Bianchini et al, 2006).  In contrast,  reduced PAT hyperemia ratios were 
consistently observed in endothelial dysfunction patients with reduced brachial artery 
FMD (Kuvin et el., 2003)  and in healthy patients, higher FMD values were 
accompanied by higher PAT hyperemia ratios (Kuvin et el., 2003).  As noted in this 
study,  FMD and PAT have contrasting macro and micro vascular properties, yet these 
techniques were found to be strongly associated with each other, challenging the 
author’s  hypothesis that no correlations were expected between the two tools (Dhindsa 
et al., 2008).  The evidence presented above suggests that PAT could be a 
complementary approach to aid in the detection of patients at risk for CVD, and may 
even be used as an alternative method, as PAT is more user friendly than FMD. 
The Effects of Exercise on Vascular Function 
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A sedentary lifestyle is closely linked to an increased risk for heart disease, 
whereas exercise, both aerobic and anaerobic, has been found to produce favorable 
outcomes on cardiovascular health.  In addition to being a successful cardiovascular 
disease preventative measure, exercise can also be a crucial component of cardiac 
rehabilitation following myocardial infarction. (Chandrashekhar & Anand, 1991).  In 
fact, exercise significantly reduces systolic and diastolic blood pressure, which is turn 
decreases cardiac mortality rate by 5-9% (Ohkubo et al., 2001). 
During exercise, vascular adaptations occur to meet the working muscle's 
significantly higher metabolic needs.  These adaptations will differ accordingly with 
various exercise types and intensities.  Some of these adaptations include increased 
blood pressure, blood flow and shear stress  (Tanaka, H., 2006).  Shear stress is the 
parallel frictional force that blood applies to the vessel wall as it flows, and it is closely 
linked to endothelium dependent vasodilation due to increased NO production 
(Woodman, Price, & Laughlin, 2005).  Along with an increase in shear stress, dynamic 
low-intensity handgrip exercises have been shown to  intensify flow mediated dilation 
of the brachial artery in healthy subjects further supporting the link between shear stress 
and increased vascular function (Mcgowan, C. et al., 2006; Tanaka, H., 2006).  In fact, 
a linear relationship exists between FMD and shear stress, demonstrating a dose 
response depending on the amount of stimulus inflicted by shear stress (Rognmo et al., 
2008). Additionally, Rognmo et al reported a negative correlation between FMD resting 
artery diameter; therefore smaller vessels will experience greater shear stress and 
greater FMD responses.  Furthermore, at the onset of exercise, there is a rapid increase 
in blood velocity and therefore blood flow as observed via ultrasound Doppler 
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(Shoemaker, Hodge, & Hughson, 1994).  Some of these responses are observed only at 
specific exercise intensities , as acute moderate-intensity exercise was shown to 
increase blood pressure and FBF, while acute mild-intensity exercise did not cause 
these changes in young healthy males (Goto et al., 2007).  Although this study was 
unable to test this relationship during high-intensity exercise due to large body 
movements, it was determined that the vasodilation observed during moderate-intensity 
exercise occurred due to an increase in NO bioavailability.  Exercise induced vascular 
improvements have been found to occur throughout the entire vasculature, and are not 
limb specific. Enhanced FMD, vascular remodeling and vasodilatory capacity of 
conduit and resistance vessels of the upper limbs were reported following 
predominantly lower limb exercises (Walther et al., 2008). 
Chronic exercise training.  The beneficial effects of chronic exercise on vascular 
function have been thoroughly studied and are well understood. The advantageous 
effects of aerobic exercise include but are not limited to improved oxygen uptake from 
working muscle and cardiac output while resistance exercise increases bone density and 
muscular strength (Rubattu, 2007).  Several studies have observed significant 
improvements in vascular health, specifically changes in vessel structure following 
endurance and resistance exercise training.  Following a 2 hour per day, 6 day 
endurance exercise training program, a significant decrease was observed in central and 
peripheral arterial stiffness evaluated via peripheral pulse wave velocity (PPWV) in 
healthy young males (Currie, Thomas, & Goodman, 2009).  Arteries, composed of 
elastin and collagen, are prone to lose their elasticity, which negatively affects vascular 
function.  The significant decreases in arterial stiffness observed in the previously 
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mentioned study were due to adaptive responses of the body to a short term exercise 
program.  Vascular adaptations to long term exercise training have also been evaluated.  
Although a 2-year long endurance and strength training program resulted in an 
improved cardiovascular risk profile in patients with Diabetes Mellitus (DM), there 
were no indications of significant improvement in arterial stiffness (Loimaala et al., 
2009).  The observed discrepancy between short-term and long-term exercise training 
effects on arterial stiffness may not be due to the length of the exercise program, but 
rather the decreased baseline levels of elastin in the vessels of patients with DM 
(Loimaala et al., 2009).  In a recent study that employed FMD via ultrasound following 
an acute bout of resistance exercise on 10 healthy, moderately active men, an increase 
in blood flow, therefore in vasodilatory capacity, was detected (Collier et al., 2010). As 
shown through these studies, resistance exercise indeed enhances several aspects of 
vascular function. 
Acute exercise training.  More recently, the greater number of studies have evaluated  
the effects of acute bouts of exercise, and the results have been inconsistent.  Several 
studies have found significant improvements in cardiovascular function following a 
bout of acute exercise in different diseased and healthy populations.  Immediately 
following an acute bout of aerobic exercise, it was found that flow mediated dilation 
increased in obese patients with impaired vascular function (Zhu et al., 2010) and 
impaired microvascular endothelial function was restored by an acute bout of lower 
limb exercises in post-surgical varicose vein patients (Klonizakis, Tew, Michaels, & 
Saxton, 2009).  Acute exercise resulted in a nearly two-fold increase in brachial artery 
flow mediated dilation, as well as significant increases in total peripheral conductance 
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in healthy sedentary normotensive postmenopausal women, yet these changes were not 
observed in premenopausal women ( Harvey et al., 2005).  In a more recent study, a 
two-fold increase in FBF was observed following a single bout of aerobic exercise, and 
a similar increase was seen after a single bout of resistance exercise in a group of 
healthy, moderately active young men (Collier et al., 2010).  Another recent study 
utilized FMD to compare the effects of different intensities of acute exercise bouts on 
post-prandial decreases of endothelial function.  The study found that moderate 
intensity exercise preceding a high-fat meal diminished endothelial dysfunction in 
comparison to control subjects who did not endure the single bout of moderate intensity 
exercise.  In addition, this study found that an acute bout of high intensity interval 
exercise exceeded the protective effects of the acute bout of moderate intensity, 
significantly increasing flow mediated dilation regardless of the post-prandial lipedemia 
(Tyldum, 2009).  
 As exercise intensity increases, the working muscles, including the heart, 
require increased oxygen use and delivery to meet increasing demands.  Forearm blood 
flow and vascular reactivity have been assessed by SGP in healthy, sedentary subjects 
following an acute maximal exercise test, with both FBF and vascular reactivity being 
significantly enhanced (Bousquet-Santos, Soares, & Nóbrega, 2005).  Moreover, 
vascular reactivity was still elevated 60 minutes post-exercise, indicating subacute 
effects of a bout of maximal aerobic exercise on vascular function (Bousquet-Santos, 
Soares, & Nóbrega, 2005).   
Despite the robust evidence of the beneficial effects of acute bouts of exercise 
on cardiovascular health, several studies have found opposing results.  Acute exercise 
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was found to aggravate endothelial dysfunction, marked by a decreased in flow 
mediated dilation in patients with intermittent claudication (Sylvestro et al., 2002).  
Similar findings marked by a decrease in brachial artery FMD were seen 
following an acute bout of isometric handgrip exercises in patients medicated for 
hypertension (Mcgowan, C. et al., 2006).  It is a strong possibility that the contradicting 
findings from the previously mentioned studies may be population and disease specific.  
Further investigation of the effects of acute bouts of different intensities on endothelial 
dysfunction in healthy, unmedicated populations is clearly warranted.  
Acute exercise, although beneficial to cardiovascular health in specific 
populations, seems to also be a stressor to the cardiovascular system, aggravating 
already existing risk factors and diseases in others (Sylvestro et al., 2002).  Application 
of this concept in CVD detection and prevention efforts has been successful, and is now 
a pivotal part of diagnostic testing.  CVD diagnostic testing consisted of testing patients 
with an electrocardiogram (EKG) test at rest. EKGs have been the gold standard 
diagnostic test for CVD detection as they provide relevant prognostic information such 
as cardiac abnormalities including left ventricular hypertrophy, Q waves, ST segment 
changes, left bundle branch block, atrial fibrillation, and other factors associated with 
CVD (Möhlenkamp, Wieneke, Sack, Erbel, 2007). In fact, performing myocardial 
perfusion imaging at rest within 2 to 6 hours of pain chest symptoms detects patient’s 
risk level for acute myocardial infarction (Tatum et al., 1997).  
 As demonstrated above, exercise-induced vascular function alterations vary in 
type and magnitude. This is particularly important in diseased populations, which have 
shown diminished vascular function following an acute bout of exercise (Sylvestro et al.; 
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Mcgowan, et al., 2006). The ability of exercise to stress the cardiovascular system results 
in altered vascular responses, which may provide  additional prognostic data related to 
the health of the vasculature. Moreover, challenging the cardiovascular system to a safe 
point may highlight otherwise unseen cardiovascular abnormalities aiding in early 
detection of CVD precursors, and even preventing the development of CVD altogether.  
Our study attempts to evaluate three commonly used tools that normally evaluate 
vascular function at rest, following a moderate intensity acute bout of aerobic exercise. It 
is our hope that the additional exercise-induced stress on the cardiovascular system may 
further reveal signs of patients with an elevated risk for CVD to decrease their propensity 
to development, rather than detect the existence of the disease considered the world’s 
largest killers. 
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III. ABSTRACT 
 
Background:  Endothelial dysfunction (ED) is one of the earliest subclinical indicators 
of impaired cardiovascular health and several non-invasive tools have been developed to 
evaluate vascular function, including strain gauge plethysmography (SGP), brachial 
artery flow-mediated dilation (FMD) via ultrasound, and peripheral artery tonometry 
(PAT).  While these tools have extensively been studied during a resting condition, the 
responses following acute exercise are not as well characterized.  Purpose:  The purpose 
of this study was to compare the pre- and post-exercise vascular function values obtained 
with SGP, FMD, and PAT.  Relationships among the primary outcome variables obtained 
with each assessment tool were also evaluated.   Methods:  Vascular function was 
assessed in 17 sedentary, apparently healthy male subjects (24±4 yrs; 24.5±3.2 kg/m2) at 
rest and following an acute submaximal exercise bout with SGP, FMD, and PAT.  
Results:  During rest, post-occlusion reactive hyperemia resulted in significant (p<0.05) 
increases in forearm blood flow (FBF; 2.13±1.03 vs 6.35 ± 2.90 mL/min/100 mL tissue) and 
area under the curve (AUC; 226.77 ± 111.20 vs 588.22 ±283.33 mL/min/100 mL) as 
determined by SGP.  Brachial artery diameter (BAD) as assessed with FMD was 
increased by 5.3% (p<0.05).  Resting reactive hyperemia index (RHI) as assessed by PAT 
was observed to be 1.73±0.34.   Significant exercise-induced increases (p<0.05) were 
observed in baseline and post-occlusion FBF and baseline AUC values utilizing SGP.  
Additionally, FMD baseline blood velocity was significantly increased (91.8±11.1 vs 
108.0±17.1 cm/sec, p<0.05) and the PAT augmentation index (AI) was significantly more 
negative (-8.8 ±9.4 vs -18.9±8.4%, p<0.05) after exercise.  There were no significant 
correlations observed among the primary outcome measures obtained from each 
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assessment technique.  There was, however, a moderate correlation between pre-exercise 
vascular reactivity as assessed by SGP and change in blood velocity as assessed by FMD 
(r= 0.566, p= 0.035).  Conclusions:   The addition of an exercise stress to vascular 
function assessment may offer greater insight into the health of the vasculature.  This 
initial study was undertaken to further evaluate the pre- to post-exercise responses 
obtained using three commonly employed vascular function assessment techniques in 
healthy individuals.  Additional research as to the value of the addition of an exercise 
stress to vascular function assessment in individuals with traditional cardiovascular 
disease risk factors or known cardiovascular disease is warranted.  
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VI. INTRODUCTION 
 
The development of cardiovascular disease (CVD) is a gradual process consisting 
of morphological and physiological vessel changes that slowly debilitate the vasculature 
(Vane, Anggård & Botting, 1990, Quyyumi, 1995).   CVD treatment has been thoroughly 
investigated, and research efforts have recently shifted to further understanding 
prevention as well as early detection of subclinical indicators of CVD, including 
endothelial dysfunction (ED).  ED is defined as the progressive development of irregular 
vascular function, such as abnormal vessel tone, loss of the endothelium’s 
atheroprotective properties, and most notably, diminished nitric oxide (NO) availability 
(Vane, Anggård & Botting, 1990).  NO contributes to vessel homeostasis by regulating 
vascular function and mediating endothelium-dependent vasodilation (Verma & 
Anderson, 2002).  As a precursor of CVD, ED has proven to be treatable and even 
reversible by the implementation of drastic lifestyle changes such as smoking cessation, 
healthy eating habits and the adoption of an exercise regimen (Chandrashekhar & Anand, 
1991).  
Exercise has been found to produce favorable outcomes on cardiovascular 
health.  In fact, exercise significantly reduces systolic and diastolic blood pressure, 
which in turn decreases cardiac mortality rate by 5-9% (Ohkubo et al., 2001).  Chronic 
exercise is linked to an extensive range of health benefits but the effects of acute 
exercise are less clear.  Supplementary exercise-induced effects include changes in 
heart rate and cardiovascular responses such as blood pressure, blood flow, and shear 
stress (Tanaka, 2006), which  are known to improve following exercise training.  The 
effects of an acute bout of exercise on these cardiovascular responses have been found 
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to vary, and seem to be population and exercise intensity specific (Zhu et al., 2010 & 
Sylvestro et al., 2002). 
As the prevalence of CVD has dramatically risen in the last several decades (He 
& MacGregor, 2009), clinicians have become increasingly interested in obtaining valid 
and reliable measures of vascular function as a means of quantifying ED.  Several non-
invasive assessment techniques have been developed to evaluate vascular function 
including flow mediated dilation (FMD), strain gauge plethysmography (SGP), and 
peripheral artery tonometry (PAT).  These techniques assess vascular function by 
evaluating reactive hyperemic responses to a given occlusive stress; however, each 
technique evaluates post-occlusion changes in different areas of the vasculature.  
Additionally, studies employing these techniques have primarily provided data on 
vascular function at rest; however, recent research has also evaluated vascular function 
following an acute exercise bout.  Some of these findings observed during an acute bout 
of exercise include significant increases in brachial artery flow mediated dilation, as 
well as significant increases in total peripheral conductance (Harvey et al., 2005) and a 
two-fold increase in FBF following a single bout of aerobic exercise (Collier et al., 
2010).  
Acute effects of exercise were recently investigated in post-surgical varicose 
vein patients with ED.  The study found that impaired microvascular endothelial 
function was restored by an acute bout of lower limb exercises (Klonizakis, Tew, 
Michaels, & Saxton, 2009).  Despite the robust evidence of the beneficial effects of 
acute bouts of exercise on cardiovascular health, several studies have found conflicting 
results.  Acute exercise was found to aggravate endothelial dysfunction, marked by a 
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decreased in flow mediated dilation in patients with intermittent claudication (Sylvestro 
et al., 2002).  Similarly, findings marked by a decrease in brachial artery FMD were 
observed following an acute bout of isometric handgrip exercises in patients medicated 
for hypertension (Mcgowan, C. et al., 2006).  The discrepancies observed may be 
population specific, as diminished vascular function following exercise seems to be 
more predominant in diseased populations. 
  The augmented stress induced on the cardiovascular system by exercise is the 
basis for including graded exercise testing as a means of detecting CVD (Lear, Brozic, 
Myers & Ignaszewski, 1999).   As with traditional cardiovascular exercise testing, the 
inclusion of exercise as a stressor during assessment of  vascular function with tools such 
as SGP, FMD and PAT may aid in the recognition of early signs of CVD development 
and other cardiovascular abnormalities otherwise undetected by assessment at rest.  
However, there is currently no consensus on which assessment tool is most appropriate 
for a pre- and post-exercise evaluation of vascular function.  Therefore, the purpose of 
this pilot study was to evaluate pre- and post-exercise reactive hyperemic responses 
utilizing three common vascular function assessment tools: SGP, FMD, and PAT.  
Additionally, this study sought to evaluate the relationships among the primary outcome 
variables associated with each technique both before and after an acute bout of moderate 
intensity aerobic exercise.  
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VII. METHODS 
 
 
Subjects.  Apparently healthy sedentary subjects aged 19-35 years with body mass index 
(BMI) values <30 kg/m2 were recruited to participate in the study.  Subjects were asked 
to attend three research trials (SGP, FMD and PAT); randomly assigned with at least 48 
hours in between trials, to assess vascular function both at rest and following 20 minutes 
of moderate intensity aerobic exercise.   All subjects voluntarily participated in the study 
and gave written informed consent.  Each subject completed a brief medical history 
questionnaire and the short form of the International Physical Activity Questionnaire 
(IPAQ-short) prior to beginning the study.  Upon arriving for each trial, each subject’s 
weight was obtained to the nearest 0.25 kg and height was obtained to the nearest 0.25 
cm.  Subjects were subsequently placed in a supine position for a minimum of 30 minutes 
prior to any assessments. Subjects were instructed not to consume food after midnight the 
night before participating in each trial, although moderate water consumption was 
allowed until the time of the trials.  Additionally, subjects were asked to refrain from 
alcohol and tobacco consumption for a minimum of 24 hours, and to refrain from 
exercise for a minimum of 48 hours prior to each trial.  All procedures were approved by 
the VCU Institutional Review Board 
Exclusion Criteria.  Exclusion criteria for this study included any history of 
cardiovascular or metabolic disease, or if the subject was taking any medication that 
might affect cardiovascular hemodynamics, vascular function, or vascular responses to 
exercise.  Females were excluded from this pilot study as varying hormone 
concentrations during the phases of the menstrual cycle have been shown to alter vascular 
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function (Deroo & Korach, 2006).  Subjects were also excluded if they had a latex allergy 
since the assessment of vascular function with the PAT unit requires contact with an 
inflatable finger cuff made from latex.  Lastly, since exercise training is thought to alter 
vessel structure and possibly vascular function, the current study sought to recruit 
subjects that did not meet the Surgeon General’s recommendation of 30 minutes of 
moderate intensity physical activity 5 days per week as determined by the IPAQ-short. 
Assessment of Vascular Function 
 
All vascular function measurements were performed in the morning (~7:00 AM), 
in a quiet environment and at controlled ambient temperatures both at rest and following 
a 20 minute bout of submaximal exercise. 
Strain-gauge plethysmography.   Forearm blood flow was assessed using mercury-in-
rubber strain-gauge plethysmography (SGP; Model AI6, D.E. Hokanson, Inc., Bellevue, 
WA).  Methods utilized for forearm blood flow measures were similar to those previously 
reported by Bousquet-Santos et al. (2005).  A pressure cuff was placed around the upper 
right arm.  A smaller wrist pressure cuff was placed around the right wrist to occlude 
hand circulation.  A mercury-filled strain gauge was placed around the widest part of the 
forearm, 10 cm distal to the olecranon process. The arm was supported by foam supports 
at a level approximately 10° above the heart.  Electrodes were placed on the subject’s 
chest for electrocardiogram (ECG) acquisition.  Baseline forearm blood flow (FBF) 
measurements were taken by inflating the wrist cuff to 250 mmHg and then rapidly 
inflating the upper arm cuff to 40 mmHg for 4-s to occlude venous outflow, followed by 
an 8-s deflation, during each 12-s cycle.  Nine cycles were recorded to determine the 
average rate of volume change during venous occlusion (ml/100 ml of forearm tissue 
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volume/min).  Following baseline measures, the upper cuff was inflated to 240 mmHg for 
5 minutes to occlude blood flow and subsequently induce reactive hyperemia.  Upon cuff 
deflation, FBF was measured for another nine cycles.  FBF trials were analyzed using the 
Hokanson AI6 Software version 2.2.4, and subsequently exported to a spreadsheet for 
further analysis.  The values obtained at rest and following the acute submaximal exercise 
bout included baseline and hyperemic FBF (ml/100 ml of forearm tissue volume/minute), 
area under the curve (AUC), and vascular reactivity.  AUC was calculated by the addition 
of the averages of every two consecutive FBF values over the 12 second cycle time 
frame. Vascular reactivity was calculated as the difference between AUC at baseline and 
during reactive hyperemia.   
Flow mediated Dilation.  Brachial artery diameter was assessed with high resolution 
ultrasound (HDI 5000, Phillips ATL; Oceanside CA) utilizing methods similar to those 
previously reported by Peretz et al. (2007).  Approximately 15 minutes prior to the trial, a 
resting blood pressure measurement was obtained from the left arm.  For the FMD trial, 
the right arm was comfortably placed in an extended position to allow for ultrasound 
scanning of the brachial artery at a location above the antecubital fossa.  A pressure cuff 
was placed around the subject’s forearm and ECG electrodes were placed on the subject’s 
chest to obtain a corresponding ECG signal for synchronization of diameter 
measurements with the R-wave of the cardiac cycle.  All baseline and post-occlusion 
trials were recorded to Super VHS videotape for later analysis.  A longitudinal section of 
the brachial artery was located by a trained ultrasonographer and baseline brachial artery 
diameter and baseline Doppler blood velocity were recorded.  Following the baseline 
measures, the forearm pressure cuff was inflated to 240 mmHg for five minutes to 
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occlude blood flow.  At the end of the five minute occlusion period, the cuff pressure was 
quickly released and peak reactive hyperemic blood velocity was assessed and recorded 
for approximately 30 seconds.  After 45 seconds, the assessment mode was quickly 
changed to record images of the vessel diameter for the next 2 minutes to obtain peak 
diameter during reactive hyperemia.   
WinDVR software (InterVideo, Inc.) was utilized to capture baseline and post-
occlusion images for analysis.  Images for analysis of brachial artery diameter and blood 
flow velocity were captured at the end of diastole at the peak of the ECG R wave.  
Vascular regions of interest were delineated at the intima-lumen interface for brachial 
artery diameter measurements employing software developed by the  Clinical Research 
Center (CRC) at Virginia Commonwealth University.  Values obtained from each trial 
included baseline brachial artery diameter, 1 minute post-occlusion brachial artery 
diameter, average baseline blood velocity, and peak reactive hyperemic velocity.  FMD 
was calculated by dividing the post-occlusion diameter change by the baseline diameter 
and expressed as the brachial artery diameter percent change [((maximal reactive 
hyperemic diameter – baseline diameter)/baseline diameter)*100].  Lastly, reactive 
hyperemic blood velocity change was calculated by dividing the post-occlusion blood 
velocity change by the baseline blood velocity [((maximal reactive hyperemic blood 
velocity – baseline velocity)/baseline velocity)*100].  Each assessed value was obtained 
by averaging 5 baseline and 5 post-occlusion images. 
Peripheral Artery Tonometry.  Pulsatile blood volume changes in the fingers were 
determined with peripheral artery tonometry (Endo-PAT2000, Itamar Medical).  Methods 
utilized for determination of vascular function with PAT were similar to those previously 
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reported by Selamet and Tierney (2009).  A pressure cuff was positioned around each 
subject’s upper right arm and non-invasive pneumatic latex finger cuffs were placed on 
the right and left index fingers.  Pulse wave amplitude was continuously recorded from 
both fingers. The finger cuffs were inflated and one minute of measurement of pulsatile 
changes were evaluated to ensure the absence of leaks in the cuffs.   Subsequently, 
baseline measurements were obtained for 5 minutes in both the right and left index 
fingers. The pressure cuff was subsequently inflated to 240 mmHg to occlude blood flow 
for 5 minutes.  Pulsatile flow was continuously assessed during the 5 minute occlusion 
period to ensure adequate occlusion of blood flow.  Following the 5 minute occlusion 
period, the cuff was rapidly deflated and the pulsatile blood flow response to reactive 
hyperemia was assessed for an additional 5 minutes.  The EndoPAT™ automatic analysis 
software was utilized to obtain the reactive hyperemic index (RHI) and the augmentation 
index (AI) for each trial.  The RHI is the ratio of the average pulse wave amplitude 
measured over 60 seconds, starting one minute after cuff deflation, to the average pulse 
wave amplitude measured at the baseline (Syvänen, Korhonen, Partanen, & Aarnio, 
2010).  According to the Itamar Medical Manager of Cardiovascular Development, 
AI indicates the elasticity of the tunica media, an independent risk factor for CVD 
(Tirosh, R, personal communication, July 11, 2011). In addition, each trial was analyzed 
by manually selecting baseline, occlusion, and test areas as detailed by Selamet and 
Tierney (2009).  Any extraneous artifact was also marked, if present.  Test over baseline 
ratios (T/B) for both test and control arms were calculated by the EndoPAT2000™ 
software.  The test arm ratio was subsequently normalized to accommodate any changes 
in the control arm during the trial.   
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Submaximal Exercise Bout.  Following the pre-exercise assessment of vascular function, 
each subject participated in a 20 minute submaximal bout of treadmill exercise.  The 
exercise began with a three minute warm up at 3.0 MPH and 0% grade. Following the 
brief warm up, the treadmill speed and grade was set to a workload that would elicit a 
heart rate equal to 75% of the subject’s age-predicted maximum heart rate for the 20 
minute exercise bout.  Heart rate was continuously monitored throughout the exercise 
bout and minor adjustments in speed and/or grade were made and noted during the first 
trial.  Subsequent trials utilized the same speed and grade to equate the workloads 
between the three vascular function trials.  Upon completion of the 20 minute exercise 
bout, subjects were instructed to cool down for three minutes at 3.0 MPH, and 0% grade. 
Participants were immediately taken to an examination room for post-exercise vascular 
function measures.  All post-exercise vascular function measures were commenced 
within 10 minutes of completion of the exercise bout. 
Statistical Analysis.  All data are represented as mean ± standard deviation.  Paired 
samples t-tests were employed to compare baseline and post-occlusion means before and 
after exercise for each measure and pre- and post-exercise means for each vascular 
function measure.  Additionally, Pearson Product Moment Correlations were employed to 
determine relationships among pre- and post-exercise values obtained from each 
assessment tool. The α-level was set at p < 0.05 for all statistical analyses. 
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VIII. RESULTS 
Subjects 
Seventeen apparently healthy sedentary male subjects (24 ± 4.14 years; 24.5 ± 3.23 
kg/m2) voluntarily participated in the study and underwent testing with SGP, FMD and 
PAT prior to exercise and following a moderate-intensity acute bout of aerobic exercise. 
Subject population characteristics are presented in Table 1. 
Effects of exercise on hemodynamic measures 
Average heart rate during the 20 minute exercise bout was 148 ± 2 beats/min. There were 
significant increases in mean arterial pressure (86.8 ± 9.98 mmHg vs 91.8 ± 2.34 mmHg; 
p < 0.003), systolic blood pressure (117.47 ± 7.4 mmHg vs 124.35 ± 8.61mmHg; p < 
0.006) and diastolic blood pressure (71.71 ± 12.72 mmHg vs 75.76 ± 11.87 mmHg; p < 
0.014) from pre- to post-exercise.  Additional hemodynamic measures are found in Table 
1. 
Strain Gauge Plethysmography 
Pre-exercise.  SGP data were obtained on 15 subjects.  Data from 2 subjects were 
excluded from the analysis due to equipment failure during one or more of the reactive 
hyperemia trials.  Significant differences were observed between baseline FBF and post-
occlusion FBF (2.13 ± 1.03 mL/min/100 mL tissue vs 6.35 ± 2.90 mL/min/100 mL; p= 
0.005) representing reactive hyperemia-induced changes (Figure 1). Additionally, the 
calculated post-occlusion AUC values were significantly greater compared to baseline 
AUC values (226.77 ± 111.20 mL/min/100 mL vs 588.22 ± 283.99 mL/min/100 mL ; p< 
0.0001).  Pre-exercise vascular reactivity (VR) was determined to be 355.26 ± 203.39 
mL/min/100 mL.   
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Post-exercise.  During the post-exercise SGP trial, post-occlusion FBF values were 
significantly greater than baseline post-exercise values (3.0 ± 1.03 mL/min/100 mL tissue 
vs 7.61 ± 2.77 mL/min/100 mL; p< 0.0001) representing reactive hyperemia (Figure 1).  
Post-occlusion AUC values were also significantly greater than baseline values      
(375.34  ±  107.08mL/min/100 mL  vs 703.71  ±  283.16  mL/min/100 mL ; p< 0.0001).   
Lastly, post-exercise VR was observed to be 366.68 ± 210.79 mL/min/100 mL.  
Pre- to post-exercise changes in SGP.  Pre- and post-exercise baseline and post-occlusion 
SGP values are provided in Figure 1.  After exercise, baseline FBF was significantly 
greater than the pre-exercise baseline FBF (3.00 ± 1.03 mL/min/100 mL tissue vs 2.13 ± 
1.03 mL/min/100 mL tissue; p= 0.012), and post-exercise post-occlusion FBF was also 
significantly greater than its pre-exercise counterpart (7.61 ± 2.77 mL/min/100 mL tissue 
vs 6.35 ± 2.90 mL/min/100 mL tissue;  p= 0.002).  Additionally, post-exercise baseline 
AUC was significantly greater than pre-exercise baseline AUC (p= 0.008) however, there 
was no significant difference observed between pre- and post-exercise post-occlusion 
AUC values and the calculated pre- and post-exercise VR were not significantly 
different.  Pre-exercise post-occlusion FBF was significantly correlated to post-exercise 
post-occlusion FBF (r= 0.763, p=0.002) and post-exercise post-occlusion maximum FBF 
(r= 0.753, p=0.003).  A significant correlation between pre-exercise and post-exercise 
post-occlusion maximum FBF was also observed (r= 0.826 p= 0.001).  Additionally, pre-
exercise VR correlated with post-exercise VR (r= 0.742, p= 0.004), as well as pre and 
post-exercise post-occlusion AUCs (r= 0.745, p= 0.002).  
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Flow Mediated Dilation 
Pre-exercise.  Pre-exercise FMD data were obtained on 16 subjects.  One subject was 
excluded due to equipment malfunction during the pre-exercise FMD trial.  Baseline 
brachial artery diameter and average blood velocity was determined to be 4.178 ± 0.37 
mm and 91.839 ± 11.126 cm/sec, respectively.  As expected during post-occlusion 
reactive hyperemia, there was a 5.3% increase in brachial artery diameter (p< 0.0001) 
(Figure 2) and a 71.9% increase in blood velocity (p< 0.0001).  Pre-exercise FMD 
measure correlations are found in Table 3. 
Post-exercise.  Similar to the pre-exercise trial, there was a significant (p< 0.0001) 
increase of 4.9% in brachial artery diameter after the 5 minute occlusive stress (Figure 2).  
Post-exercise vascular measure correlations obtained with FMD can be found in Table 3.  
Pre- to post-exercise changes in FMD.  There were no significant differences observed 
between values obtained for baseline brachial artery diameter, post-occlusion brachial 
artery diameter, FMD percentage, or post-occlusion reactive hyperemic blood velocity 
during the pre- and post-exercise trials.  Post-exercise baseline blood velocity was, 
however, significantly (p< 0.0001) greater than pre-exercise values.  Pre- and post-
exercise vascular function measures obtained by FMD are found in Figure 2.  A strong 
positive correlation was found between baseline BAD values pre- and post exercise (r= 
0.976; p< 0.0001) as well as between pre- and post-exercise post-occlusion BAD values 
(r= 0.956, p< 0.0001).  The correlation coefficient between pre-exercise and post exercise 
FMD was 0.753 (p= 0.001).  Correlation data for FMD measures are included  in Table 3. 
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Peripheral Artery Tonometry  
Pre-exercise.  PAT data were obtained on 16 subjects. The data for one subject was 
excluded due to an equipment malfunction.  Pre-exercise RHI values were determined to 
be 1.73 ± .34.  Manual calculation of the RHI value resulted in a slightly lower mean 
value of 1.32 ± 0.335.  Mean AI value at rest was found to be -8.77 ± 9.35%. 
Post-exercise.  Post-exercise RHI values were determined to be 1.55 ± 0.191.  Manual 
calculation of the post-exercise RHI value resulted in a mean value of 1.10 ± 0.29. Mean 
AI value following exercise was determined to be -18.92 ± 8.41%.  
Pre- to post-exercise changes in PAT.  There was no significant difference observed 
between the computer-determined RHI values obtained pre- and post-exercise.  There 
was, however, a pre- to post-exercise significant difference (p= 0.022) in the manually-
calculated RHI values.  Additionally, there was a significant difference observed in the 
AI values (p<0.001).  Significant correlations were observed for AI values obtained at 
rest and AI values after exercise (r=0.627, p= 0.022).   
Relationships among Vascular Assessment Tools 
There were no significant correlations observed among the primary outcome measures 
obtained from each assessment technique.  There was, however, a moderate correlation 
between pre-exercise VR as assessed by SGP and pre-exercise change in blood velocity 
as assessed by FMD (r= 0.566, p= 0.035).  Correlations between measures obtained by 
SGP, PAT and FMD are included in Table 4. 
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IX. DISCUSSION 
 
The endothelium plays a central role in the preservation of vascular homeostasis. 
In fact, an impaired endothelium is the initial manifestation of CVD development, 
occurring long before any of the well-recognized epidemiologic characteristics of the 
onset of the disease (Wilson, 2005).  Although several endothelial function assessment 
tools have been developed, they are yet to be fully evaluated as valid tools for the early 
detection of CVD (Peretz et al., 2007; Gori et al., 2006 & Selamet Tierney, 2009).  In this 
pilot study, inter-relationships among different vascular function techniques were 
evaluated on the same subjects prior to exercise and following an acute bout of moderate 
intensity exercise. While all three techniques (FMD, SGP and PAT) in this study have 
been developed to assess vascular function following blood flow occlusion and 
subsequent post-ischemic reactive hyperemia, each technique functionally evaluates a 
different component of the vasculature to provide an indication of vascular health.  
In contrast to the thoroughly investigated effects of chronic exercise on vascular 
function, research on the effects of an acute bout of exercise on vascular hemodynamics 
is sparse.  In the current study, we have observed increases in forearm blood flow, 
forearm blood flow area under the curve, brachial artery diameter, and blood velocity 
both before and after an acute bout of moderate intensity aerobic exercise in response to a 
5 minute occlusive stress.  Additionally, we found significant differences between pre-
exercise and post-exercise values for baseline forearm blood flow, baseline forearm blood 
flow area under the curve, and post-occlusion forearm blood flow values obtained from 
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SGP.  Moreover, we observed an increase in baseline blood velocity as assessed by FMD, 
as well as a decrease in AI% as assessed by PAT.  Lastly, we found no significant 
correlations among the primary outcome measures obtained from SGP, FMD, and PAT 
either before or after exercise.   
Pre-exercise vascular function. Pre-exercise vascular function values obtained from each 
method are similar to those previously reported (Alomari et al., 2005; Peretz et al., 2007 
& Bonetti et al., 2004).  Pre-exercise SGP resulted in increased FBF and AUC values 
following a 5 minute occlusion when compared to their baseline counterparts.  AUCs 
were calculated as a flow-time index. These findings are comparable to those of Alomari 
et al., who found similar increases in post-occlusion FBF in repeated trials, as well as 
those of Bousquet-Santos et al, which measured FBF pre- and post-exercise (Alomari et 
al., 2005;  Bousquet-Santos & Soares, Nobrega, 2005).    
Pre-exercise flow mediated dilation via ultrasound revealed significant increases 
in blood velocity and BAD values following the 5 minute occlusive stress.  These results 
are in agreement with those of Peretz et al., who found significant increases from baseline 
BAD to post-occlusion BAD during a resting condition using both upper-arm and 
forearm occlusion (Peretz et al., 2007). Comparing our results to those reported by other 
similar studies, we found that BAD values for our study seem to be slightly higher, yet 
our FMD values are lower than FMD reported by others (Harvey et al., 2005; Aizer et al., 
2009, Okamoto, Masuhara & Ikuta, 2007; Rogmo et al., 2008).  Larger brachial artery 
diameters were obtained with forearm occlusion than upper arm occlusion. Distal 
occlusion has been recommended over proximal occlusion, as it produces a dilatory 
response mainly dependent on NO. 
 54
Vascular function assessment by PAT does not produce separate baseline and 
post-occlusion values. Rather, the system software automatically calculates a reactive 
hyperemia index (RHI) as well as an augmentation index (AI).  Additionally, 
test/baseline (T/B) ratios can be calculated by the system software following the manual 
demarcation of baseline, occlusion and test areas for both the control and the test 
(occlusion) arms. Significant differences were found between T/B1 (test arm) and T/B2 
(control arm) reflecting reactive hyperemia-induced vascular changes. The mean resting 
RHI value in the current study was found to be 1.73 ± 0.34, values which reflect a healthy 
endothelium as expected from an apparently healthy population. These values are similar 
to those found by Bonetti et al., who reported a RHI value of 1.78 ± 0.08 in subjects with 
normal coronary endothelial function (Bonetti et al., 2004). The average pre-exercise AI 
value, which represents vessel elasticity, was -8.769 ± 9.347.  While very few studies 
have measured AI, this measure may become a variable of greater interest for future 
studies, as AI is considered an independent CVD risk factor (Tirosh, R, personal 
communication, July 11, 2001).  
Post-exercise vascular function.  Post-exercise vascular function responses as detected by 
the SGP, FMD and PAT were variable in comparison to pre-exercise values.  As 
observed during pre-exercise measurements, significant increases were also observed in 
FBF and FBF AUC values as assessed by SGP from baseline to post-occlusion following 
the acute exercise bout.  These findings are similar to those of Bousquet-Santos et al., 
who also observed significant increases in baseline and post-occlusion blood flow 
following exercise.  However, in contrast to their findings that reported an augmentation 
in VR shortly after, and 60 minutes after exercise, we did not observe a significant 
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increase in this value. As previously mentioned, AUC represents a flow-time index 
calculated from baseline and post-occlusion FBF measures respectively. Specifically, 
AUC is calculated by adding the means of each pair of two consecutive FBF measures, 
each pair which has been divided by the length of each cycle (12 seconds).  Elevations in 
FBF due to exercise will in turn result in elevated AUC values.  Due to this elevation 
following exercise, non-significant differences in VR are not entirely surprising since  
augmentations in AUC will in turn decrease post-exercise VR values.  Although the SGP 
methodology of the current study was modeled after the technique of Bousquet-Santos et 
al., their exercise intervention consisted of an acute bout of maximal rather than moderate 
intensity exercise. The difference in exercise intensities between the two studies may be 
the cause of the discrepancy in VR findings, as higher exercise intensities are known to 
cause greater acute vascular responses (Harris, Padilla, Hanlon, Rink & Wallace, 2008). 
 Significant increases in post-occlusion BAD and velocity from their respective 
baseline values were detected by FMD following exercise.  These findings are in 
agreement to those of Harvey et al., in which vascular function was assessed in post-
menopausal women (Harvey et al., 2005).  Unlike Harvey et al., we found no statistical 
significance in the difference between resting and post-exercise values for BAD, FMD 
and also post-occlusion blood velocities.  In addition to the previously mentioned study, 
other studies that reported significant increases in BAD and improvements in FMD 
following similar exercise protocols in diseased and healthy populations (Padilla et al., 
2009, & Zhu et al., 2007).  In contrast, other studies revealed that acute exercise was 
found to aggravate endothelial dysfunction, marked by a decreased in flow mediated 
dilation in patients with intermittent claudication (Sylvestro et al., 2002).  Similar 
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decreases in brachial artery FMD were seen following an acute bout of isometric 
handgrip exercises in patients medicated for hypertension (Mcgowan, C. et al., 2006).  
Although these discrepancies may be population or disease specific, further investigation 
of NO-dependent vasodilation responses after exercise is certainly warranted.  
Additionally, standardization of FMD methodology is of paramount importance in order 
to allow comparisons among published studies. 
Analysis of the post-exercise data obtained via PAT revealed significantly 
different values in AI but not in RHI.  The post-exercise mean AI% value was found to 
be  -18.923 ±  8.411%, a value indicative of healthy, elastic vessels.  T/B1 representing 
the occluded arm was slightly higher than the T/B2 ratio for the control arm, 
demonstrating the effects of blood flow occlusion. The T/B ratios have no clinical value 
but are have been utilized for research purposes to look at changes in blood flow in 
comparison to the control arm. Comparing pre-exercise to post-exercise values obtained 
by PAT revealed statistically significant differences between resting and post exercise 
T/B1 ratios of the test arms, reflecting altered reactive hyperemic responses to exercise. 
This significance was not observed between pre-exercise and post-exercise T/B2 ratios 
for the control arm. Interestingly, RHI values were lower following exercise, denoting 
endothelial dysfunction. There have been no studies assessing vascular function with 
PAT at rest and following exercise.  
To our knowledge, there have been no studies comparing all three vascular 
function assessment tools pre and post-exercise. However, there have been several 
studies comparing different combinations of two of these tools both during a resting 
condition (pre-exercise) and following different exercise protocols.  Unlike a limited 
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number of previous studies, we found no significant correlations among the primary 
outcome measures obtained from each assessment technique.  Strong correlations were 
found between SGP and FMD in a study that utilized FBF and forearm volume to 
calculate diameter changes in the brachial artery (Sinoway, Hendrickson, Davidson WR 
Prophet & Zelis, 1989).  These calculations were made under the assumption that blood 
that reaches the forearm travels mostly through the brachial artery.  No such correlations 
were observed in our study prior to or after exercise. We did, however, find a moderate 
correlation between pre-exercise VR and pre-exercise changes in blood velocity as 
assessed by FMD.  Our lack of correlation in vascular function measures by SGP and 
FMD has been supported by previous research.  For example, when FMD was compared 
against SGP during a resting condition, it was found that there was no significant 
correlation between the two (Eskurza, I., Seals, D., DeSouza., Christopher A &Tanaka, 
H.,2001; Gori at al. 2006).  A major difference between this study and the current study is 
the use of intrabrachial artery infusion of acetylcholine, commonly known for its 
vasodilatory properties as a stimulus for FBF.  Although both methods assess peripheral 
vascular endothelial vasodilatory capacity, each method gauges vascular function of 
distinct vessel types, dictated by unique molecular mechanisms. NO controls vasoactivity 
of conduit vessels (FMD) via endothelial cells, yet FBF of the resistance vessels is 
partially (≈ 50%) controlled by smooth cells (Ferrara, et al., 2006).   
Conversely, PAT evaluates the microcirculation of capillary networks.  The 
differences in molecular mechanisms dictating vascular reactivity of different vessel 
types may explain the lack of significance in correlation analysis found in our study.   In 
a comparison study, Bianchini et al. reported no correlation between vascular function 
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values obtained via PAT and FMD (Bianchini et al, 2006).  However, Dihndsa et al, 
whose population was very similar to ours, found PAT and FMD to be strongly 
associated with each other (Dhindsa et al., 2008). 
 Several factors have been shown to influence the vascular function values 
obtained from the assessment tools employed in this study.   These include the state of 
the vascular health of the population evaluated, methodology differences, and whether 
these assessments are performed at rest or following exercise (Harris, Padilla, Hanlon, 
Rink & Wallace, 2008; Gori at al. 2006; & Sylvestro et al., 2002).  If post-exercise 
assessment is being performed, exercise intensity and the length of the exercise bout may 
be features worth further investigation. 
Our results must be interpreted within the context of several study limitations.  
First, our population size was small, thereby limiting statistical power. Additionally, our 
population consisted of young, sedentary and apparently healthy individuals.  In such 
populations, one can expect cardiovascular systems free of exercise-induced training 
effects, age-related deterioration, and disease. These characteristics are not representative 
of the general public, and thus may limit our ability to apply these findings. The use of an 
apparently healthy population in this pilot study limits the variability of vascular 
measures, reducing the likelihood of obtaining statistically significant differences. As 
SGP, FMD and PAT are manufactured to detect subclinical vascular abnormalities such 
as ED, future studies will benefit from the inclusion of a population possessing CVD risk 
factors to compare against a control population such as ours.  Another noteworthy factor 
to consider is the exercise intensity required for significant vascular responses to occur, 
particularly in an apparently healthy population. Acute moderate-intensity exercise was 
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shown to increase blood pressure and FBF, while acute mild-intensity exercise did not 
cause these changes in young, healthy individuals (Harris, Padilla, Hanlon, Rink & 
Wallace, 2008).  Incorporating an exercise bout of higher intensity than the submaximal 
exercise bout used in our study may intensify exercise-induced vascular responses. The 
additional stress that higher intensity exercise applies to the cardiovascular system may 
improve the effectiveness of endothelial dysfunction assessment with SGP, FMD and 
PAT in apparently healthy individuals.  Alternatively, exercising the limb being assessed 
may yield more relevant vascular function findings. Limb specific exercises such as 
handgrip exercises have previously been successfully employed in the assessment of 
vascular function, and may be a worthy addition to the current study’s methodology 
(McGowan et al., 2006).  Although exercise is an effective addition to CVD diagnostic 
testing, as employed during stress tests, more specific exercise intensity parameters may 
be needed when attempting to detect pre-cursors in individuals without overt disease.  
 In this pilot study, reactive hyperemic vascular responses were investigated both 
before and after a submaximal aerobic exercise bout with SGP, FMD and PAT in a 
sedentary, apparently healthy population.  Pre-exercise vascular responses were mostly 
similar to those found by other studies with similar populations; however, we observed 
variable responses in post-exercise measures.  Exploring relationships among the 
vascular measures assessed by SGP, FMD and PAT before and after exercise may 
provide a more comprehensive insight into exercise-induced effects on the vasculature.  
Gaining an understanding of expected vascular responses for healthy individuals will aid 
in providing a foundation for vascular response evaluation of individuals with CVD risk 
factors and diseased populations.  In our study, no correlations between the three tools 
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were found at rest and following exercise. Future research should consider the addition of 
populations at different CVD risk levels, as well as populations formally diagnosed with 
CVD to further investigate the diagnostic power and clinical use of an exercise stressor in 
conjunction with SGP, FMD and PAT to improve ED detection and CVD prevention. 
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X. TABLES 
 
Table 1. Subject Demographics  
 
 
Variable                                                                                 Mean (±sd) 
 
N                                                                                               17  
Age (years)                                                                               24.1   ±  4.14                                 
Height (cm)                                                                              182.5 ±  6.93 
Weight (kg)                                                                              81.5   ±  10.37 
BMI (kg/m2)                                                                            24.5    ±  3.23 
Resting Systolic BP (mm Hg)                                                 117.5  ±  7.40  
Resting Diastolic BP (mm Hg)                                               71.7    ±  12.72 
Resting MAP                                                                           86.81  ±  9.98  
Post-exercise MAP                                                                  91.80  ±  9.58                                                   
Post-exercise Systolic BP (mm Hg)                                        124.4  ±  8.61 
Post-exercise Diastolic BP (mm Hg)                                      75.8    ±  11.87 
Exercise HR (bpm)                                                                 148  ±  2 
 
Abbreviations: BMI, body mass index; BP, blood pressure; HR, heart rate; MAP, mean arterial pressure 
 
 
Table 2. Pre and Post-exercise vascular function measures obtained from each of the three 
assessment tools 
 
Measure Pre-Exercise Post-Exercise 
SGP (N= 15)     
Baseline FBF (mL/min/100 mL tissue)   2.13  ±  1.03   3.00  ±  1.03* 
Post-Occlusion FBF (mL/min/100 mL tissue)   6.35  ±  2.90     7.61  ±  2.77 * 
Baseline AUC   226.77  ±  111.20           375.34  ±  107.08* 
Post-Occlusion AUC   588.22  ±  283.33      703.71  ±  283.16 * 
VR  355.26  ±  203.39     366.67  ±  210.79 * 
FMD (N= 16)   
Baseline BAD (mm)   4 .178  ±  0.376    4.188 ±  0.399 
Post-Occlusion BAD (mm)    4.397  ±  0.376      4.387 ±  0.374  
FMD (%)    5.33  ±  3.02    4.88  ±  2.99  
Baseline Blood Velocity (cm/sec)    91.839  ±  11.126     108.00  ±  17.09 * 
Post-Occlusion Blood Velocity (cm/sec)         160.067  ±  21.39   172.73  ±  27.37  
PAT (N= 16)   
RHI   1.73  ±  0.34  1.55  ±  0.19 
AI (%)  -8.77  ±  9.35 -18.92  ±  8.41* 
   
 
Abbreviations: BAD, brachial artery diameter; FMD, flow mediated dilation; RHI, reactive hyperemic index; AI, 
augmentation index; FBF, forearm blood flow; AUC, area under the curve; VR, vascular reactivity. *p< 0.05 
 62
 
Table 3. Correlation between vascular measures as assessed by FMD 
 
 
 PE FMD PE BL BAD        PE PO BAD         PR PO BAD 
PR FMD 0.753** (P< 0.001)                      -                 -                 - 
PR BL BAD                   - 0.976** (P< 0.000) 
    0.917** 
  (P< 0.000) 
          0.944** 
         (P< 0.000)  
PR PO BAD                    - 0.943** (P< 0.000) 
           0.956** 
        (P< 0.000)                1 
 
Abbreviations: PR, pre-exercise; PE, post-exercise; BL, baseline; PO, post-occlusion;  post-exercise; BV, blood 
velocity ; FMD, flow-mediated dilation ; BAD, brachial artery diameter. 
*P< 0.05; ** P< 0.01 
 
 
 
Table 4. Correlation between vascular measures as assessed by SGP, FMD and PAT 
 
 
 
PR VL     PE FMD 
PR VR       0.566* 
   (P< 0.035) 
      0.564* 
    (P< 0.045) 
PE AI            - 
 
            - 
PE RHI      - 0.272 
   (P< 0.346) 
       0.000 
     (P< 0.999) 
PE VR       0.511 
   (P< 0.074) 
      0.087 
     (P< 0.788) 
 
 
Abbreviations: PR, pre-exercise; PE, post-exercise; BL, baseline; PO, post-occlusion;  post-exercise; VR, vascular 
reactivity ; VL, blood velocity ; FMD, flow-mediated dilation  AUC, area under the curve. 
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XI.FIGURES 
 
 
Figure 1. Changes between baseline and post occlusion FBF pre and post-exercise
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Figure 2. Pre and Post-Exercise Changes in Baseline and Post-Occlusion BAD 
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RESEARCH SUBJECT INFORMATION AND CONSENT FORM 
 
 
TITLE: A PRE AND POST EXERCISE COMPARISON OF THREE ASSESSMENT TOOLS 
COMMONLY EMPLOYED TO EVALUATE VASCULAR FUNCTION 
 
 
 
VCU IRB PROTOCOL NUMBER:   
 
INVESTIGATORS: Ronald K. Evans, Ph.D., Lorena P. Salom, B.S. 
 
SPONSOR:   
 
This consent form may contain words that you do not understand.  Please ask the study 
staff to explain any words or information that you do not clearly understand.  You may 
take home an unsigned copy of this consent form to think about or discuss with family or 
friends before making your decision. In this consent form, “you” always refers to the 
subject. 
 
PURPOSE OF THE STUDY 
The purpose of this study is to compare three different types of equipment that are commonly 
used to measure how blood vessels function by either measuring blood flow or changes in vessel 
size.  We will be taking these measures while you are at rest and after 20 minutes of moderate 
intensity exercise on a treadmill.   
 
DESCRIPTION OF THE STUDY  
Blood vessels are lined with a single layer of cells called the endothelium that influences 
blood vessel diameter.  Endothelial dysfunction is considered to be the earliest clinical 
sign of increased cardiovascular disease risk and early detection of changes in this cell 
layer may be beneficial for identifying individuals at higher risk for future cardiovascular 
events.  Brachial artery flow-mediated dilation (FMD) via ultrasound, venous occlusion 
strain-gauge plethysmography (SGP), and peripheral artery tonometry (PAT) are 
commonly employed non-invasive tools for the evaluation of vascular function. Your 
participation in this study will last up to three weeks.  Approximately 20 subjects will 
participate in this study.  
 
PROCEDURES 
If you decide to be in this research study, you will be asked to sign this informed consent form 
after you have had all of your questions answered.  Whether or not you qualify for this study will 
be based upon your physical characteristics and medical history. The criteria for inclusion in this 
study are as follows:  Sedentary males between 25-35 years of age with body mass index (BMI) 
values <30 kg/m2.  You will complete a medical history form prior to the beginning of the study. 
You may not have any history of cardiovascular or metabolic disease, or be taking any 
medication that might affect blood flow, blood vessel function, or the blood vessel  responses to 
exercise. You will also be excluded if you have a latex allergy since the assessment of vascular 
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function with one of the techniques (PAT) requires contact with an inflatable finger cuff made 
from latex. Testing sites include the Health and Human Performance Lab at 3600 W. Broad St. 
and the General Clinic Research Center (GCRC) on the VCU Medical Center campus.  
Participation in this study will require that you visit the testing sites on three occasions 
approximately 1 week apart. During each visit, you will undergo baseline vascular function 
assessment with one of the techniques, followed by a submaximal exercise bout, and concluding 
with post-exercise vascular function assessment. Each visit will last approximately 2 hours. 
 
The following measurements will be made during the study: 
 
Anthropometric Measures.  Your weight and height will be assessed with a scale and 
stadiometer. These measurements will be utilized to calculate your BMI. These 
measurements will be performed at 3600 W. Broad Street in the Health and Human 
Performance Laboratory on your first visit. These measures will take approximately 10 
minutes to complete. 
 
Blood vessel.  Blood flow through your vessels will be assessed using three different techniques: 
Strain Gauge Plethysmography, Flow Mediated Dilation and Peripheral Artery Tonometry, each 
which will last approximately 35 minutes.  
• Strain Gauge Plethysmography: Blood pressure cuffs will be positioned around your 
upper right arm and right wrist, and a mercury-in-rubber strain gauge will be placed 
around your forearm. During each trial, the wrist cuff will be inflated to a pressure of 240 
mmHg prior to each measurement to occlude hand circulation.  Baseline FBF will be 
determined by rapidly inflating the upper cuff to 40 mmHg for 4 seconds. Then, the 
upper arm cuff will be inflated to 240 mmHg to induce forearm ischemia for a period of 5 
minutes. After 5 minutes of occlusion, the cuff will be released and FBF, as described 
above, will be determined during a 9 consecutive 12-second cycles. 
• Flow Mediated Dilation: Brachial artery diameter at rest will be assessed with high 
resolution ultrasound. Following the resting measures, a blood pressure cuff will be 
positioned around your upper left arm and inflated to suprasystolic pressure to produce 
ischemia for a period of 5 minutes. Following cuff release, your vessel diameter will be 
reassessed  
• Peripheral Artery Tonometry: A blood pressure cuff will be positioned around your upper 
right arm and finger cuffs will be placed on your right and left index fingers.  Baseline 
blood flow changes will be measured for 5 minutes in both your right and left index 
fingers prior to inflating the blood pressure cuff on your right upper arm to approximately 
200 mmHg to induce a 5 minute period of forearm ischemia. Following cuff release, your 
pulsatile blood flow changes will be reassessed.  
 
Physical Activity Participation.  Physical activity participation will be assessed at your first visit 
using a physical activity recall questionnaire.  This questionnaire will ask you questions about 
the quantity and intensity of your physical activity over the previous 7 days.  The questionnaire 
will take approximately 5 minutes to complete.  
 
Submaximal Exercise Bout.  The submaximal exercise bout will begin with a three 
minute warm up period on the treadmill at 3.0MPH, and 0% grade. You will then 
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exercise on the treadmill at 75% of your age-predicted maximum heart rate for twenty 
minutes. A brief cool down period of three minutes in length at 3.0MPH will follow the 
exercise bout. You will then be taken to an examination room for post-exercise vascular 
function measures. 
 
 
 
RISKS AND DISCOMFORTS 
Inflation of the cuff may cause discomfort, pain and tingling in your hands and fingers. As with 
any exercise participation, there is also the slight chance of an abnormal blood pressure response, 
fainting, and disorders of heart beat. In the event of a medical problem during testing, the 
technicians will administer emergency first aid and then activate the appropriate emergency 
medical system. 
 
BENEFITS TO YOU AND OTHERS 
You are not expected to receive any direct medical benefits from your participation in the 
study. You will not receive any monetary compensation for your participation. However, 
information from this study will help us better understand the similarities and differences 
between techniques that assess vascular function. 
 
COSTS 
There are no costs for participating in this study other than the time commitment for the 
three testing sessions. 
 
 
ALTERNATIVE 
This is not a treatment study.  Your alternative is not to participate in this study. 
 
CONFIDENTIALITY  
Potentially identifiable information about you will consist of medical history forms, 
measures of blood vessel function, body mass index, and physical activity participation.  
Data are being collected for research purposes only.  Your data will be identified by a 
unique identifier, your name, and stored in a locked research area in the Health and 
Human Performance Laboratory at 3600 W. Broad Street.  All personal identifying 
information will be kept in password protected files and these files will be deleted within 
two years following the completion of the study.  Access to all data will be limited to 
study personnel. 
 
You should know that research data about you may be reviewed or copied by Virginia 
Commonwealth University.  Personal information about you might be shared with or 
copied by authorized officials of the Federal Food and Drug Administration, or the 
Department of Health and Human Services (if applicable). Although results of this 
research may be presented at meetings or in publications, identifiable personal 
information pertaining to participants will not be disclosed.   
 
COMPENSATION FOR INJURY 
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Virginia Commonwealth University and the VCU Health System have no plan for 
providing long-term care or compensation in the event that you suffer injury as a result of 
your participation in this research study. 
 
If you are injured or if you become ill as a result of your participation in this study, 
contact a member of the research team immediately.  A member of the study staff will 
arrange for short-term emergency care if it is needed. 
 
Fees for such treatment may be billed to you or to appropriate third party insurance.  
Your health insurance company may or may not pay for treatment of injuries as a result 
of your participation in this study. 
 
 
 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
Your participation in this study is voluntary.  You may decide to not participate in this 
study.  Your decision not to take part will involve no penalty or loss of benefits to which 
you are otherwise entitled.  If you do participate, you may freely withdraw from the study 
at any time.  Your decision to withdraw will involve no penalty or loss of benefits to 
which you are otherwise entitled. 
 
Your participation in this study may be stopped at any time by the study doctor or the 
sponsor without your consent. The reasons might include: 
• the study staff thinks it necessary for your health or safety; 
• you have not followed study instructions; or 
• administrative reasons require your withdrawal. 
 
 
QUESTIONS 
In the future, you may have questions about your study participation. You may also have 
questions about a possible side effect, reaction to study medication, or a possible 
research-related injury. If you have any questions, complaints, or concerns about the 
research, contact: 
 
Ronald K. Evans, PhD 
Department of Health and Human Performance 
804-828-7798 
rkevans@vcu.edu 
 
If you have questions about your rights as a research subject, you may contact: 
 
Office of Research 
Virginia Commonwealth University 
800 East Leigh Street, Suite 113 
PO Box 980568 
 83
Richmond, VA  23298 
(804) 827-2157 
 
You may also contact this number for general questions, concerns or complaints about 
the research.  Please call this number if you cannot reach the research team or wish to talk 
to someone else. 
 
Do not sign this consent form unless you have had a chance to ask questions and have 
received satisfactory answers to all of your questions.  Additional information about 
participation in research studies can be found at 
http://www.research.vcu.edu/irb/volunteers.htm. 
 
CONSENT  
 
I have been provided with an opportunity to read this consent form carefully.  All of the 
questions that I wish to raise concerning this study have been answered.   
 
By signing this consent form, I have not waived any of the legal rights or benefits, to 
which I otherwise would be entitled.  My signature indicates that I freely consent to 
participate in this research study.  I will receive a copy of the consent form once I have 
agreed to participate. 
 
 
________________________________________________ 
Subject Name, printed 
 
 
________________________________________________ ________________ 
Subject Signature        Date 
 
 
________________________________________________ 
Name of Person Conducting Informed Consent  
Discussion / Witness 
(Printed) 
 
________________________________________________ ________________ 
Signature of Person Conducting Informed Consent   Date 
Discussion / Witness  
 
 
________________________________________________ ________________ 
Investigator Signature (if different from above)    Date  
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Department of Health and Human Performance 
 
A Pre and Post Exercise Comparison of Three Assessment Tools Commonly 
Employed to Evaluate Vascular Function 
 
- Please no do consume food or drinks after midnight the night before participating in the  
 
study. Moderate water consumption is allowed. 
 
- No alcohol or tobacco for a minimum of 24 hours prior to your appointment. 
 
- Please refrain from exercise for a minimum of 48 hours prior to your appointment 
 
- Please wear or bring comfortable clothes and shoes for your treadmill test. 
- Please remove all fingernail polish on your index fingers prior to your visit.  
- When you arrive at the GCRC, you will be placed in a room and allowed to rest for a 
minimum of 30 minutes prior to your testing session. 
I. Directions to VCU Medical Center: 
Arriving by I-64 West - coming from Virginia Beach, Williamsburg, etc. 
1. Take Exit #190 for 5th Street and Downtown/Coliseum  
2. Turn left at the 4th traffic light onto Marshall Street  
3. Drive six blocks and turn left onto 11th Street  
4. Drive one block and turn right onto Clay Street  
5. Go one and one-half blocks to the Patient and Visitor Parking Decks E & S. 
Arriving by I-64 East - coming from Charlottesville, I-81, etc.  
1. Follow I-64 East which merges with I-95 South  
2. Remain on I-95 south to Exit #74C for West Broad Street  
3. Proceed West on Broad Street and follow directions given under "arrive by I-95 
North" 
Arriving by I-95 North - coming from Petersburg, North Carolina, etc.  
1. Take Exit #74C for West Broad Street  
2. Proceed West on Broad Street for three blocks to 11th Street, take right  
3. Drive two blocks to Clay Street and turn right  
4. Proceed one and one-half blocks to the Patient and Visitor Parking Decks E & S. 
Arriving by I-95 South - coming from Washington, Fredericksburg, etc.  
1. Take Exit #74C to West Broad Street  
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2. Follow directions given under "arriving by I-95 North" 
Arriving by U.S. Route 60 - coming from Lexington, etc.  
1. Follow U.S. Route 60 which merges with 9th Street  
2. Remain on 9th Street and go one block past Broad Street to Marshall Street and turn 
right  
3. Drive two blocks and turn left onto 11th Street  
4. Drive one block and turn right onto Clay Street  
5. Go one and one-half blocks to the Patient and Visitor Parking Decks E & S. 
• Valet parking is available for $5.00 at the entrances of the Gateway Building, ACC 
and North Hospital. Parking for the Children’s Pavilion is available in the Pavilion’s 
lower garage on 11th St. for $5.00. 
• The VCU Medical Center has a Patient and Visitor Parking Deck located at 12th and 
Clay Streets. The Deck is open 24 hours daily. There is a charge for using this facility 
during the week. 
• Reduced parking rates at the Visitor Parking Deck ($2.00 per visit) are available for 
patients and visitors that obtain parking validation at the Information Desks located 
on the first floor of ACC and Children’s' Pavilion; ground floor of Gateway and 
Critical Care Hospital.   
• Lost parking tickets for the Patient and Visitor Parking Deck will be charged $10.00 
upon exit unless a $2.00 validation is presented. 
 
 
vp Valet Parking    P General Parking  
 87
• Arrive at the General Clinical Research Center (8th floor North Hospital) at least 
15 minutes prior to your appointment time.  North Hospital is accessible from the 
Gateway building (Main entrance).  Go up the escalators; walk straight, all the 
way down the hallway (past the cafeteria), transition into North Hospital.  Around 
the corner you will see a set of elevators.  Go to 8th floor (GCRC). 
 
II. Directions  to 3600 West Broad Street (Health and Human Performance 
Laboratory): 
 
Arriving by I-64 West - coming from Virginia Beach, Williamsburg, etc. 
 
1. Take exit 70 towards Boulevard 
2. Turn slight left to take the ramp toward VA-161 
3. Turn left onto Hermitage Rd 
4. Turn right onto Robin Hood Rd 
5. Turn left onto Boulevard/VA-161 for 0.9 miles 
6. Turn right onto W. Broad St/ US-250 
7. 3600 W. Broad St is on the right after 0.6 miles 
 
Arriving by I-64 East - coming from Charlottesville, I-81, etc.  
 
1. Merge onto I-195 S via exit 79 toward US-60 W/Powhite Pkwy/ US 360W 
2. Take the Hamilton St. exit toward US-33/US-250/BROAD ST 
3. Take the ramp toward US-33/US-250/BROAD ST. 
4. Turn left onto W. Broad St/US-  250 
5. Arrive at 3600 W. Broad St on your left. 
 
Arriving by I-95 North - coming from Petersburg, North Carolina, etc.  
 
1. Merge onto I-195 N via exit 74 A toward VA-195-Toll/Downtown Expressway 
2. Take exit toward US-33/US-250/Broad St 
3. Turn slight right onto W. Clay St. 
4. Turn right into Roseneath Rd. 
5. Turn right onto W. Broad St/US-250/US-33 
6. 3600 W. Broad St/ US-250/US-33 
 
Arriving by I-95 South - coming from Washington, Fredericksburg, etc 
 
6. Merge onto I-195 S via exit 79 toward US-60 W/Powhite Pkwy/ US 360W 
7. Take the Hamilton St. exit toward US-33/US-250/BROAD ST 
8. Take the ramp toward US-33/US-250/BROAD ST. 
9. Turn left onto W. Broad St/US-  250 
10. Arrive at 3600 W. Broad St on your left. 
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Arriving by U.S. Route 60 - coming from Lexington, etc 
 
1. Merge onto I-64 E towards I-81/Staunton via exit 221 for 31 miles 
2. Marge into I-195S via exit 186 towards Powhite Parkway 
3. Take the Hamilton St. exit towards US-250/Broad St 
4. Turn slight right onto N. Hamilton St. 
5. Turn left onto W. Broad St. 
6. Arrive at 3600 W. Broad St. on the left 
 
 
• There is a parking lot in the back of the building. Please park in the last row, 
facing the highway.  
• If you have any questions regarding your appointment, please do not hesitate to 
contact Lorena Salom at 240-476-7640. The General Clinical Research Center 
can be contacted at 828-9101. 
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APPENDIX D 
RANDOMIZED SELECTION 
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1. SGP 
2. Endo-PAT 
3. Ultrasound 
4. SGP 
5. Endo-PAT 
6. Ultrasound 
7. SGP 
8. Endo-PAT 
9. Ultrasound 
10. SGP 
11. Endo-PAT 
12. Ultrasound 
13. SGP 
14. Endo-PAT 
15. Ultrasound 
16. SGP 
17. Endo-PAT 
18. Ultrasound 
19. SGP 
20. Endo-PAT 
21. Ultrasound 
22. SGP 
23. Endo-PAT 
24. Ultrasound 
25. SGP 
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APPENDIX E 
STRAIN GAUGE PLETHYSMOGRAPHY DETAILED METHODS 
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                STRAIN GAUGE PLETHYSMOGRAPHY DETAILED METHODS 
 
Subject should rest in the supine position on stretcher for about 30 minutes 
prior to testing. Turn on arterial inflow system by switching power button to the 
ON position. The switch is located on the top right corner of the cart, behind the 
computer screen. Then, press the power button on the central processing unit to 
turn on computer. Using the mouse, double click on the green AI6 icon on 
desktop to open AI6 program. 
Ask subject to raise their dominant arm, and to bend their elbow. Find 
olecranon process on the subject’s dominant arm and measure approximately 
10cm distal to the olecranon process to find widest part of the forearm and mark 
arm with a pen. Measure the circumference around the forearm of the dominant 
arm, and record. Select a strain gauge that is 2 to 3cms smaller than forearm 
circumference. Wrap large blood pressure cuff around the upper dominant arm 
tightly. A small blood pressure cuff  should be tightly wrapped around dominant 
arm’s wrist. This cuff will be inflated to suprasystolic pressures to completely 
occlude hand circulation during test; therefore isolating forearm circulation. Make 
sure both blood pressure cuffs are connected to the inflators on the cart.  
Carefully loop mercury-filled strain gauge around the widest part of the forearm, 
previously marked. The strain gauge strands should be even around the forearm, 
with both bands parallel to one another. Secure strain gauge in place by hooking 
the end of the mercury-filled band over the plastic head of the strain gauge. Place 
a small piece of adhesive tape over the plastic head to secure strain gauge to arm. 
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Plug in strain gauge to jack labeled “Strain Gauge 1” on the AI6 cart. The 
dominant arm should be raised approximately 10° above heart level by supporting 
the upper arm and hand with foam blocks. Avoid placing foam blocks on the 
forearm, as the strain gauge should not be touched. Ask the subject to be still and 
refrain from speaking, as this instrument is very sensitive to motion. Apply three 
electrodes to subject’s chest; two just below the clavicle on both sides. The third 
electrode should be placed on the left side, on the anterior axillary line, slightly 
above the navel. The skin should be prepped by briskly rubbing it with an alcohol 
pad. Shave off excess hair if necessary. Once all electrodes are applied, connect 
white Electrocardiogram (ECG) lead to the right upper electrode, the black lead to 
the upper left electrode, and the red lead to the lower left electrode.  
Running the test: 
Phase 1 
Click on “Patient” on the top right corner of the screen, then on “Enter 
Demographics”. Fill out the required fields, Patient ID and Last Name.  Click 
“Close”. This will store information on database. Check Pressure Settings box on 
the bottom right corner of the screen. Desired Wrist Pressure should be set at 250 
mm Hg for total occlusion. Desired Venous Pressure should be set at 40mmHg.  
Click “SGP Balance” to manually calibrate and zero the plethysmographs. The 
AI6 will recalibrate the plethysmograph prior to each reading during arterial flow 
measurements. Press the “Start” button to begin test. Nine measurements will be 
recorded to determine the average rate of volume change during venous occlusion 
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(ml/100 ml of forearm tissue volume/min). Pause test following the end of the 
ninth measurement. This demarcates the end of Phase 1. 
Phase 2: 
1. Check “Ischemic Stress” box, located in the Pressure Settings box on the bottom 
right corner of the screen. Stress Pressure should be set to 240mm Hg, and the stress 
period should be set at 300 seconds. Click on the “Resume” button at the bottom 
right corner of the screen to start the ischemic stress period.  The upper arm cuff will 
inflate to 240 mm Hg to induce forearm ischemia for a period of five minutes (300s). 
Following the five minute long Ischemic stress period, the cuff will be quickly 
deflated and forearm blood flow will be determined in the same manner as Phase 1. 
Allow for 9 post-ischemia test stages then click to End Test. 
Repeat procedure following acute exercise bout. 
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APPENDIX F 
 
FLOW MEDIATED DILATION VIA ULTRASOUND DETAILED METHODS 
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FLOW MEDIATED DILATION VIA ULTRASOUND DETAILED METHODS 
 
The subject should be in the supine position, resting for thirty minutes 
prior to the start of the research trial. Position the subject so that the arm is in a 
comfortable position for imaging the brachial artery. Place large blood pressure 
around the forearm of test arm, and acquire a resting blood pressure measurement 
in the control arm. Apply three electrodes to subject’s chest; two just below the 
clavicle on both sides. The third electrode should be placed on the left side, on the 
anterior axillary line, slightly above the navel. The skin should be prepped by 
briskly rubbing it with an alcohol pad. Shave off excess hair if necessary. Once all 
electrodes are applied, connect white Electrocardiogram (ECG) lead to the right 
upper electrode, the black lead to the upper left electrode, and the red lead to the 
lower left electrode.  
The brachial artery should be located on the test arm by a trained 
ultrasonographer. Once the vessel has been located, data collection can begin. 
Press the record button for 10 to 12 heart beats, then press the “Pulse” button and 
correct the angle so that it is parallel to the vessel. Adjust the baseline to the 
appropriate values, then press HighQ. Continue to record for 10 to 12 beats for 
baseline flow. Press record again to pause recording. Inflate blood pressure cuff to 
240mm Hg and start stop watch. At 4 minutes 30 seconds, press the record button. 
At 4 minutes 45 seconds, press pulse, correct the angle and press update. When 
the stopwatch marks 5 minutes, release the pressure from the blood pressure cuff, 
and press reset on the VCR timer. Continue to capture flow measurements until 
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flow start to noticeably drop, which will occurs in 20 to 25 seconds. Press the 
update button and pulse to get back to the vessel diameter screen. Continue to 
record the best image possible for 2 minutes post occlusion. Repeat procedure 
following the acute exercise bout.  
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APPENDIX G 
ENDO PAT DETAILED METHODS 
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ENDO PAT DETAILED METHODS 
 
Turn on Endo-PAT unit at least twenty minutes prior to test to allow machine to 
warm up. Turn on laptop and connect it to the Endo-PAT unit. Attach the fingertip like 
bio-sensors to apparatus. The bio-sensor probes are lined with latex; therefore subjects 
with latex allergies should be excluded from participating in the research study.  
Click on Endo-PAT icon on the desk top. Once program has opened, a green EndoPAT™ 
icon should light up at the right bottom corner of the screen, indicating communication 
between the computer and the Endo-PAT unit. Click on “Patient ID” and fill out patient 
information.  
Prior to the start of each research trial, subjects should rest in the supine position for 
thirty minutes. Resting blood pressure should be taken on the control arm approximately 
half way through the resting period. Check the subject’s finger nails, they should be short 
and clean. Nails that protrude more than five mm from the fingertip should be trimmed. If 
there is nail polish on the nails, remove it with acetone. Remove all jewelry from the 
subject.   Place finger probes on the subject’s index fingers, and blue foam anchor around 
the middle finger. The foam anchor should be pushed down towards the root of the 
finger. Place blood cuff around the upper arm of the control arm. Both arms should be 
placed at the sides of the subject’s body and elevated to heart level by resting the arms on 
the specialized blue cushions. The index fingers should be placed inside the finger holes 
at the top of the specialized cushions to avoid the finger probe to come in contact and 
provide support. Inflate finger cuff by pressing the inflate button on the Endo-PAT unit.  
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Press the yellow Standby button for one minute. Then, press the green “Go” icon to start 
recording data. Collect baseline data for a minimum of three minutes ( says that should be 
for at least 5 to10 minutes?). Quickly inflate blood pressure cuff to 240 mmHg to occlude 
blood floor to the arm for a total of five minutes. Rapidly deflate blood pressure cuff and 
continue to collect data for another three minutes. Click the “Stop” button to end test.  
Patient set up: 
Prior to the start of each research trial, subjects should rest in the supine position for 
thirty minutes. Resting blood pressure should be taken on the control arm approximately 
half way through the resting period. Check the subject’s finger nails, they should be short 
and clean. Nails that protrude more than five mm from the fingertip should be trimmed. If 
there is nail polish on the nails, remove it with acetone. Remove all jewelry from the 
subject.   Place finger probes on the subject’s index fingers, and blue foam anchor around 
the middle finger. The foam anchor should be pushed down towards the root of the 
finger. Place blood cuff around the upper arm of the control arm. Both arms should be 
placed at the sides of the subject’s body and elevated to heart level by resting the arms on 
the specialized blue cushions. The index fingers should be placed inside the finger holes 
at the top of the specialized cushions to avoid the finger probe to come in contact and 
provide support. Inflate finger cuff by pressing the inflate button on the Endo-PAT unit. 
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APPENDIX H 
 
TREADMILL OPERATION 
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TREADMILL OPERATION 
 
 
1) Turn on system. Button is on the right hand side of the system 
2) Press Ctrl+ Alt+ Del 
3) Password is “User” 
4) Once the program has loaded, click on “next page” until reaching “TEST-DEMO” 
in the Select patient (local database) window, then press “Select”.  
5) A window will come up that states “No Connection to BP”, Click OK 
6) Press the blue Exercise button on the left side of the panel right above the 
keyboard. Then, click blue “Start Treadmill” button on the right side of the panel.  
a. Increase speed for warm up to 3.0 MPH for 3 minutes. 
b. Increase speed to reach 75% of the subject’s age predicted max HR, 
exercise bout lasts for 20 minutes. 
c. Decrease speed for cool down to 3.0 MPH for 3 minutes. 
7) Press the red “Stop treadmill” button on the right hand side. 
8) Press the blue “Test end” button on the left hand side of the panel. 
9) Click Yes on the “Test end” window. 
10) Click OK on the next window that appears. 
11) Click OK on the BP window if it appears. 
12) Click on the “Initial Screen” button on the right upper corner of the screen. 
13) Click OK on the window that says “The patient ECG waveforms will no longer to 
displayed” 
14)  Press “Turn off Program”. Then click Yes on the “Do you want to terminate the 
program and shut down the device” window. This turns off the system.     
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